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A B S T R A C T
Background
Occupational irritant hand dermatitis (OIHD) causes significant functional impairment, disruption of work, and discomfort in the
working population. Different preventive measures such as protective gloves, barrier creams and moisturisers can be used, but it is not
clear how effective these are. This is an update of a Cochrane review which was previously published in 2010.
Objectives
To assess the effects of primary preventive interventions and strategies (physical and behavioural) for preventing OIHD in healthy
people (who have no hand dermatitis) who work in occupations where the skin is at risk of damage due to contact with water, detergents,
chemicals or other irritants, or from wearing gloves.
Search methods
We updated our searches of the following databases to January 2018: the Cochrane Skin Specialised Register, CENTRAL, MEDLlNE,
and Embase. We also searched five trials registers and checked the bibliographies of included studies for further references to relevant
trials. We handsearched two sets of conference proceedings.
Selection criteria
We includedparallel and cross-over randomised controlled trials (RCTs)which examined the effectiveness of barrier creams,moisturisers,
gloves, or educational interventions compared to no intervention for the primary prevention of OIHD under field conditions.
Data collection and analysis
We used the standard methodological procedures expected by Cochrane. The primary outcomes were signs and symptoms of OIHD
developed during the trials, and the frequency of treatment discontinuation due to adverse effects.
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Main results
We included nine RCTs involving 2888 participants without occupational irritant hand dermatitis (OIHD) at baseline. Six studies,
including 1533 participants, investigated the effects of barrier creams, moisturisers, or both. Three studies, including 1355 participants,
assessed the effectiveness of skin protection education on the prevention of OIHD. No studies were eligible that investigated the effects
of protective gloves. Among each type of intervention, there was heterogeneity concerning the criteria for assessing signs and symptoms
of OIHD, the products, and the occupations. Selection bias, performance bias, and reporting bias were generally unclear across all
studies. The risk of detection bias was low in five studies and high in one study. The risk of other biases was low in four studies and
high in two studies.
The eligible trials involved a variety of participants, including: metal workers exposed to cutting fluids, dye and print factory workers,
gut cleaners in swine slaughterhouses, cleaners and kitchen workers, nurse apprentices, hospital employees handling irritants, and
hairdressing apprentices. All studies were undertaken at the respective work places. Study duration ranged from four weeks to three
years. The participants’ ages ranged from 16 to 67 years.
Meta-analyses for barrier creams, moisturisers, a combination of both barrier creams and moisturisers, or skin protection education
showed imprecise effects favouring the intervention. Twenty-nine per cent of participants who applied barrier creams developed signs
of OIHD, compared to 33% of the controls, so the risk may be slightly reduced with this measure (risk ratio (RR) 0.87, 95%
confidence interval (CI) 0.72 to 1.06; 999 participants; 4 studies; low-quality evidence). However, this risk reduction may not be
clinically important. There may be a clinically important protective effect with the use of moisturisers: in the intervention groups, 13%
of participants developed symptoms of OIHD compared to 19% of the controls (RR 0.71, 95% CI 0.46 to 1.09; 507 participants; 3
studies; low-quality evidence). Likewise, there may be a clinically important protective effect from using a combination of barrier creams
and moisturisers: 8% of participants in the intervention group developed signs of OIHD, compared to 13% of the controls (RR 0.68,
95% CI 0.33 to 1.42; 474 participants; 2 studies; low-quality evidence). We are uncertain whether skin protection education reduces
the risk of developing signs of OIHD (RR 0.76, 95% CI 0.54 to 1.08; 1355 participants; 3 studies; very low-quality evidence). Twenty-
one per cent of participants who received skin protection education developed signs of OIHD, compared to 28% of the controls.
None of the studies addressed the frequency of treatment discontinuation due to adverse effects of the products directly. However, in
three studies of barrier creams, the reasons for withdrawal from the studies were unrelated to adverse effects. Likewise, in one study of
moisturisers plus barrier creams, and in one study of skin protection education, reasons for dropout were unrelated to adverse effects.
The remaining studies (one to two in each comparison) reported dropouts without stating how many of them may have been due to
adverse reactions to the interventions. We judged the quality of this evidence as moderate, due to the indirectness of the results. The
investigated interventions to prevent OIHD probably cause few or no serious adverse effects.
Authors’ conclusions
Moisturisers used alone or in combination with barrier creams may result in a clinically important protective effect, either in the long-
or short-term, for the primary prevention of OIHD. Barrier creams alone may have slight protective effect, but this does not appear
to be clinically important. The results for all of these comparisons were imprecise, and the low quality of the evidence means that our
confidence in the effect estimates is limited. For skin protection education, the results varied substantially across the trials, the effect
was imprecise, and the pooled risk reduction was not large enough to be clinically important. The very low quality of the evidence
means that we are unsure as to whether skin protection education reduces the risk of developing OIHD. The interventions probably
cause few or no serious adverse effects.
We conclude that at present there is insufficient evidence to confidently assess the effectiveness of interventions used in the primary
prevention of OIHD. This does not necessarily mean that current measures are ineffective. Even though the update of this review
included larger studies of reasonable quality, there is still a need for trials which apply standardised measures for the detection of OIHD
in order to determine the effectiveness of the different prevention strategies.
P L A I N L A N G U A G E S U M M A R Y
Treatments to prevent hand skin irritation in the workplace
Review question
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In this review, we set out to assess the available evidence on the effect of barrier creams, moisturisers, gloves, and educational programmes
for employees who are at risk of developing irritation of the skin on the hands. We found nine studies. None of them investigated
protective gloves. The evidence in this review is current to 17 January 2018.
Background
Occupational irritant hand dermatitis (OIHD) is a skin disease that occurs on the hands of employees in certain jobs. The first signs
are red and scaly patches in the finger webs and on the knuckle area of the hands. Itchy blisters, painful cracks, and possibly infection
are common, and eventually the skin becomes thickened.
Hand skin irritation can affect employees who regularly come into contact with water, detergents, chemicals, and other irritants, or
who wear gloves during their working day. People at particular risk include hairdressers, nurses, cleaners, builders, and people who
work in the dye, printing, metal, and food industries. The condition is relatively common and affects about 5 to 20 out of 10,000 full-
time workers per year. Preventing OIHD from developing is important because it is difficult to clear once it starts.
Study characteristics
We included nine studies in this review, involving 2888 male and female workers aged between 16 and 67. The studies included several
types of workers: metal workers, dye and print factory workers, gut cleaners in swine slaughterhouses, cleaners and kitchen workers,
hospital employees, and hairdressing apprentices. We were unable to find out whether or not the preventive measures were equally
effective in all these professions because there were too few trials. The studies lasted from four weeks up to three years.
Key results
Some of the preventive measures may reduce the risk of hand skin irritations. However, there were too few studies to be sure of this.
The studies were too different from each other to combine in a meaningful way, and the results were too imprecise. Our results are
therefore still debatable.
Various barrier creams, moisturisers, and skin protection education programs were investigated. It is possible that barrier creams may
slightly reduce the risk of developing OIHD. This result was based on four studies. In these studies, 29% of people who applied barrier
creams developed hand skin irritations. In the control group, who did not apply barrier creams, 33% developed hand skin irritations.
The results of three studies showed that moisturisers may reduce the risk of developing OIHD by a useful amount. Thirteen per cent
of the people who used moisturisers developed hand skin irritations, compared to 19% of those who did not use moisturisers. Two
studies showed that using a combination of barrier creams and moisturisers may reduce the risk of developing OIHD by a useful
amount. Eight per cent of the people who used moisturisers and barrier creams developed hand skin irritations, compared to 13% of
the control group. Based on three studies, we are uncertain whether skin protection education reduces the risk of developing OIHD.
In these studies, 21% of the people who received skin protection education developed hand skin irritations, compared to 28% of the
people in the control group.
The safety and tolerability of these measures were not systematically addressed in these studies. However, no serious reactions to the
treatments were reported. Mild reactions like itching or reddening of the skin were reported for only few people who applied the barrier
creams or moisturisers. The measures to prevent hand skin irritations probably cause only few or no serious adverse effects.
Quality of the evidence
For barrier creams, moisturisers, or a combination of both, the quality of the evidence was low concerning the prevention of OIHD.
There was not enough information and hand dermatitis was assessed differently across the studies.
For educational programmes, the quality of the evidence was very low concerning the prevention of hand skin irritation. There was
not enough information, hand dermatitis was assessed differently across the studies, and the studies were poorly conducted in some
important respects.
For the other key outcome, safety and tolerability of the treatments, the quality of the evidence was moderate because only indirect
results were available.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Barrier creams compared to no treatment for preventing occupational irritant hand dermatitis
Patient or population: workers at risk of occupat ional irritant hand dermatit is
Setting: metal or dye/ print factories
Intervention: barrier creams
Comparison: no treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no treatment Risk with barrier
creams
The proport ion of
part icipants developing
any signs and symp-
toms of OIHD (incident
cases) measured by
clinical scores (IGA) or
hand dermatit is scores
(e.g. HECSI, Manus-
core), or both, as
rated by the invest iga-
tor (physician/ nurse) or
the part icipant (propor-
t ion of OIHD)
Follow up: range 6
months to 12 months
Study populat ion RR 0.87
(0.72 to 1.06)
999
(4 RCTs)
⊕⊕©©
LOW 1
334 per 1000 291 per 1000
(241 to 354)
Frequency of treatment
discont inuat ion due to
adverse ef fects
Follow up: range 2
weeks to 12 months
All dropout reasons were unrelated to the treatment: the numbers of
part icipants who dropped out of the individual trials ranged f rom 0% to
24%
111
(3 RCTs)
⊕⊕⊕©
MODERATE2
Information only avail-
able f rom dropout anal-
yses, which were not
designed to detect ad-
verse ef fects
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*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI). The risk in the comparison group is based on mean proport ion observed in the comparison groups
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io; OIHD: occupat ional irritant hand dermatit is
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded by two levels. Downgraded one level for imprecision because the conf idence intervals were wide and included
1 as well as a clinically signif icant relat ive risk (0.75 or less). Downgraded one level for inconsistency because criteria for
the diagnosis of OIHD varied across the included studies; signs and symptoms of OIHD were assessed by dermatologists,
by study personnel, or by the part icipants.
2 Downgraded by one level due to the indirectness of the results. None of the studies reported direct ly on treatment
discont inuat ion due to adverse ef fects. Instead, the extracted results are based on dropout analyses, which did not focus
on adverse ef fects. For the remaining two studies in this comparison the dropout analyses were not detailed enough to
extract whether or not adverse ef fects were among the reasons. It cannot be fully excluded that some of the part icipants who
completed these studies may have stopped applying the products without the researchers’ knowledge.
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B A C K G R O U N D
Description of the condition
Definition and epidemiology
Occupational hand dermatitis is the most frequent work-related
skin disease in many Western countries (Diepgen 2003). The
two major subgroups are occupational irritant hand dermati-
tis (OIHD) and occupational allergic hand dermatitis (OAHD)
(Johansen 2011). This review focuses on OIHD and especially on
the primary prevention of OIHD in healthy individuals, because
preventing the development of dermatitis may help to reduce the
development of severe and chronic dermatitis, and possibly related
outcomes such as loss of employment (Brans 2016; Wulfhorst
2011). Studies of interventions which treat existing OIHD with
the aim of preventingworsening of symptoms or repeat episodes of
OIHD or those studies which focus on improving existing symp-
toms do exist, but are outside the scope of this review.
Occupational irritant hand dermatitis (OIHD) is an inflamma-
tory response of the skin on the hands after contact with various
irritant factors, such as water, detergents, soaps, solvents, gloves,
food, and oils which cause direct damage to the skin (Lodi 2000;
Skoet 2004). Clinically, OIHD shows a wide range of symptoms
from acute, to subacute and chronic. Morphologically the clinical
features in acute cases range from redness, oedema, and vesicula-
tion, to thickening of the skin, hyperkeratosis, desquamation, and
fissuring in chronic cases. Itching, burning sensations, and cracks
are the most common complaints, sometimes leading to pain and
infection ( Johansen 2011;McFadden 2001). Mild dermatitis typ-
ically starts in the finger webs and the knuckle areas of the hands.
In moderate cases the area enlarges to the back of the hands and
the fingers. In severe cases the entire hands and the wrists can be
affected, and there may also be pain or infection.
Occupational allergic hand dermatitis (OAHD) is caused by sen-
sitisation to contact allergens, e.g. metals, fragrance and fragrance-
related allergens, rubber ingredients, and preservatives. Skin le-
sions usually appear between 24 and 48 hours after direct skin con-
tact with the allergens, at the contact point. Signs and symptoms
resemble that of OIHD. In chronic cases, this can lead to diag-
nostic difficulties. Diagnostic patch testing with a standard series
of allergens can help rule out a contact allergy as a contributing
factor (Johansen 2011).
Epidemiological data on the incidence of occupational hand der-
matitis in Europe and the USA are available from occupational
skin disease registers from Ministries of Labour and insurance or-
ganisations. Other sources are case series and cross-sectional stud-
ies in occupations that are at high risk of occupational hand der-
matitis. Despite differences in definitions and ways of registration,
the pattern of occupational skin diseases is similar in Europe and
the USA. In most Western countries occupational hand dermati-
tis has been the most frequent, or at least the second most fre-
quent, occupational disease in recent years, accounting for approx-
imately 30% of the total occupational disease burden (Burnett
1998; Cherry 2000; Diepgen 2003; DGUV 2008; Karjalainen
1998). On the basis of different data sources, Diepgen and Coen-
raads calculated an incidence rate of registered occupational hand
dermatitis of about 5 to 20 cases per 10,000 full-time workers per
year (Diepgen 1999). In reality the figures are probably consid-
erably higher than this due to the well known phenomenon of
under-diagnosis and under-reporting of occupational diseases for
fear of job loss (Diepgen 2002; Meding 1987; Smit 1993).
Causes
Occupational irritant hand dermatitis (OIHD) occurs mainly in
employees who perform a high amount of ’wet work’ in their occu-
pational life, e.g. hairdressers, health professionals, food industry
workers, metal workers, and brick layers who have to frequently
expose their hands to wet working conditions as part of their job.
Additionally, in outdoor occupations winter weather might nega-
tively influence the skin condition. OIHD results from continued,
unprotected, low-grade exposure to mild irritants such as deter-
gents, soaps, solvents, water, food ingredients, and cutting oils or
fluids but also from the frequent wearing of gloves, and develops
when the regenerative capacities of the skin are exhausted and con-
tact with the irritants continues (Diepgen 1996; Johansen 2011;
Malten 1981).
In addition to external factors, other endogenous factors have been
identified as risk factors for the development of OIHD. Patients
with a proven tendency for atopic dermatitis were shown to be
at higher risk of developing OIHD of the hands when working
in occupations where the skin is at risk of damage (Bauer 1997;
Bauer 1998; Bauer 2001; Coenraads 1998; Dickel 2003; Smit
1994; Uter 1998a; Uter 1999). The role of other attributes, such
as age, sex, genetics, and ethnic differences, in predisposing people
to OIHD are still unclear (Diepgen 1999; Kezic 2009).
Impact
Occupational irritant hand dermatitis (OIHD) is not a life-threat-
ening disease and mild forms do not usually interfere with daily
life to a large extent, but in more severe cases the impact of OIHD
on all aspects of an individual’s quality of life can be considerable
(Jowett 1985; Boehm 2012). It may cause long-term illness with
uncertain prognosis, social isolation, and eventually unemploy-
ment or change of occupation (Cvetkovski 2005; Lerbaek 2008;
Meding 2005). This can be devastating in times of high unem-
ployment and limited government social support (Meding 1990).
The costs of OIHD for the individual and social security systems
are likely to be significant (Diepgen 2013; Mathias 1985; Politiek
2016; Saetterstrøm 2014).
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Assessment
Signs, symptoms, and severity of OIHD can vary from redness
and dryness of the skin to chronic dermatitis with thickening and
fissuring. Assessments of the severity of OIHD can be reported in
a number of ways using different scores, which include qualita-
tive and quantitative measures of signs and symptoms (erythema,
oedema, vesiculation, dryness, scaling, hyperkeratosis, fissuring,
itching, burning) and the area of hands involved. Recently several
validated scoring systems for assessing the severity of hand der-
matitis have been established, such as the hand eczema severity
index (HECSI) by Held 2005, and the Osnabrück Hand Eczema
Severity Index (OHSI) and Manuscore by Dulon 2009. The im-
pact of the condition on employees is also reflected in the numbers
staying or leaving the occupation due to OIHD.
Bioengineering methods can measure changes in the skin’s barrier
functionor hydration evenbefore visible changes appear.One such
bioengineering method is tewametry, a technique that measures
the amount of water that is lost through the outside layer of the
skin (known as TEWL, transepidermal water loss). TEWL values
are reported as g/m²h (amount of water lost from skin measured
in gram per square metre per hour). Very often, inflamed skin does
not hold water very well, and as a result the water in the body is
lost more easily through the disrupted outer layer of the skin. An
increase in TEWL has been demonstrated in cases of diseased or
damaged skin, reflecting the impairment of the barrier function
(Pinnagoda 1989). TEWL is typically used as an objectivemeasure
in clinical evaluation (Pinnagoda 1990).
Corneometry, another bioengineering method, is a tool used to
measure the levels of skin hydration in healthy and diseased skin,
i.e. how much water the skin holds. It is widely used to assess the
efficacy of skin care and protection ointments in hydrating the
stratum corneum. The stratum corneum, which is made of dead
skin cells, is the outer layer of the skin and has an important barrier
function (Fischer 1998; Leveque 1983).
Description of the intervention
The principles and methods of prevention strategies in occupa-
tions at high risk of OIHD are well defined. First line prevention
strategies are based on technical-organisational hazard control, e.g.
automation of processes, replacing the need of workers to expose
their skin to irritants, the replacement of dangerous substances by
less toxic, less irritative, or less allergenic ones. Examples of addi-
tional strategies include changing the environment by substitution
of wet work and encouraging changes in worker behaviour such
as frequency of hand washing. Since these first options are more
fundamental than personal protection, they are usually given pri-
ority over the other measures, but if these strategies cannot be put
into action, individual protective measures, e.g. protective gloves,
barrier creams, and moisturisers, are recommended.
Barrier creams/skin protection creams
A barrier cream, also called skin protection cream, is a topical
preparation that is applied to the skin to provide a barrier, helping
to reduce the effect of skin contact with contaminants. Barrier
creams are used to protect employees against work-related skin
hazards. Ideally they are specially designed for and adapted to
the profile of the workplace. Barrier creams are recommended for
use before work, and two to three times during work time when
necessary.
Under experimental conditions there is evidence that barrier
creams show protective effects against the acute irritation caused
by solvents (Mahmoud 1984; Mahmoud 1985). Different skin
protection products have been shown to prevent or significantly
reduce detergent-induced irritation (Frosch 1994; Patterson 1999;
Schliemann 2014; Zhai 1996). The effects of barrier creams on
improvement of OIHD in hairdressers has been reported (Bock
2001).However, an international survey revealed that themajority
of international experts are sceptical about the specific properties
of barrier creams (Hogan 1990).
Moisturisers/emollients/skin care creams
Moisturisers, also called emollients or skin care creams, are used
for regenerative skin care during and after work, and should be
applied regularly during work time after hand washing, and after
work at home to support the regenerative capacities of the skin
(Halkier-Sørensen 1993; Mathias 1990; Wigger-Alberti 1997).
Protective gloves
Protective gloves are meant to be used when contact with toxic
or irritant substances, allergens, or infectious material should be
avoided. Although it is widely accepted that gloves protect against
irritants, allergens, and microbial agents, there are concerns that
occlusive gloves themselves are a substantial factor in the promo-
tion of OIHD and OAHD if not used properly (Ramsing 1996;
Rose 2009; Wrangsjö 1994).
Complex interventions using barrier creams,
moisturisers, and protective gloves
Barrier creams and gloves combined with adequate moisturisers
are widely recommended as the most important means of personal
protection in professions where the skin is at risk. Various in vivo
and in vitromethods have investigated their efficacy (Boman 1989;
Fluhr 2007; Frosch 1994; Gabard 1995; Henry 1994; Mellström
1994; Treffel 1994; Wahlberg 1996).
Skin protection education
Most studies reveal a considerable lack of knowledge of ex-
posed workers regarding the essential aspects of skin protection
(Wulfhorst 2011). Skin protection education may address varying
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aspects of preventingOIHD.This includes advice on how to apply
barrier creams, moisturiser, and gloves. Also, workers can be ad-
vised to reduce the extent of hand washing and wet work or avoid
wearing jewellery at work. Practical training can be included as
part of educational interventions for exposedworkers. Behavioural
interventions supported by health psychological approaches are
used to promote the dissemination of knowledge concerning skin
protection. Apart from practical training, these may include role
models, working groups, and reminders. The programmes will be
described individually for the included studies.
How the intervention might work
Barrier creams/skin protection creams
Barrier creams are meant to provide a thin layer on the skin and
thereby help to reduce contact to irritants. The layer is thought
to facilitate the removal of contaminants, thereby reducing the
irritations of intensive hand washing (Kütting 2008; Mathias
1990). Barrier creams can also contain active ingredients which
may trap or transform irritants (Frosch 1994; Lachapelle 1996;
Zhai 2006). It is however controversial if there exists an essential
difference between barrier creams andmoisturisers or if this is only
a matter of timing (before versus after exposure).
Moisturisers/emollients/skin care creams
Moisturisers are topical preparations that use a variety of agents
designed to increase the hydration of the outer layers of the skin by
reducing water loss from the skin. Moisturisers have been shown
under experimental and real-life conditions to have significant pre-
ventive and therapeutic effects. They prevent irritant skin reac-
tions induced by detergents and have been shown to accelerate
the regeneration of a disrupted barrier in irritated skin (De Paepe
2000; Loden 1997; Ramsing 1997; Williams 2010; Zhai 1998).
Protective gloves
Gloves are worn in order to reduce contact to irritants.
Skin protection education
Providing knowledge about skin protection can help workers at
risk of OIHD to adopt an adequate preventive behaviour. The
potential benefit of skin protection education is indirect because
it also depends on the effectiveness of the advised measures. As
knowledge alone does not guarantee the uptake of preventive be-
haviour it may be reasonable to include behavioural and psycho-
logical elements which aim to overcome impediments and pro-
mote the workers’ motivation to protect their skin.
Why it is important to do this review
Occupational irritant hand dermatitis (OIHD) may cause serious
problems for the individuals affected and their families. Even with
social security systems in place, long-term illness, unemployment
or the necessity of occupational change can affect families to a large
extent, especially in times of high unemployment, and uncertain
prospects for future employment, even after retraining.
There are many indications that protective measures may be ef-
fective in the prevention of OIHD. However, the actual benefit
of each measure, when used singly or in combination, under real-
world conditions in the work place is still unclear. In particular, it is
important to establish whether individual protection measures are
really beneficial, or whether they are potentially hazardous for em-
ployees under certain circumstances (Hogan 1990;Wigger-Alberti
1998).
This review is an update of ’Interventions for preventing occupa-
tional irritant hand dermatitis’ (Bauer 2010).
O B J E C T I V E S
To assess the effects of primary preventive interventions and strate-
gies (physical andbehavioural) for preventing occupational irritant
hand dermatitis (OIHD) in healthy people (who have no hand
dermatitis) who work in occupations where the skin is at risk of
damage due to contact with water, detergents, chemicals or other
irritants, or from wearing gloves.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomised controlled trials (RCTs) for inclusion,
which investigated the efficacy of interventions in the primary
prevention of occupational irritant hand dermatitis (OIHD), and
were conducted under normal working conditions in the work
place.We included parallel, split-body, or cross-over trials. We did
not include controlled clinical trials (CCTs) because they provide
a lower level of evidence.
Types of participants
We considered any employee in ’wet work’ occupations for inclu-
sion, where there is a risk of developing OIHD (incident cases),
e.g. nurses, hairdressers, employees in the food processing indus-
try, cleaners, metal workers, printers, bricklayers, etc.We included
only primary prevention studies and not studies where participants
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had existing hand dermatitis, unless the participant population
was mixed and disaggregated data were available for those partici-
pants who were healthy with no hand dermatitis at the start of the
study. Whether or not hand dermatitis was present at baseline was
decided based on the baseline data reported by the study investi-
gators. The diagnostic criteria were not evaluated in this regard.
Types of interventions
We included studies of interventions for the primary prevention
of OIHD, in working populations. This did not include experi-
mental studies.
Examples of primary prevention interventions include:
• barrier creams;
• moisturisers;
• protective gloves;
• complex interventions using combinations of interventions
e.g. barrier creams, moisturisers, and protective gloves;
• skin protection education.
We included studies in which interventions were compared with
another intervention or compared with no intervention.
Types of outcome measures
We included studies that measured the following outcomes, at any
follow-up time.
Primary outcomes
• The proportion of participants developing any signs and
symptoms of OIHD (incident cases) measured by clinical scores
(IGA) and/or hand dermatitis scores (e.g. HECSI, Manuscore)
as rated by the investigator (physician/nurse) or the participant.
• Frequency of treatment discontinuation due to adverse
effects. We did not perform a separate search for adverse effects
of the target intervention. However, we did examine data on
adverse effects from the included studies we identified.
Secondary outcomes
• Severity of clinical signs and symptoms in incident cases of
OIHD (measured by clinical scores (IGA) or hand dermatitis
scores, e.g. HECSI, Manuscore), or both, as rated by the
investigator (physician/nurse) or the participant.
• Proportion of participants with significant changes
(difference in average score or difference from baseline, or both)
in barrier function or hydration, measured using TEWL (skin
barrier), and corneometry (skin hydration).
• Change of occupation because of OIHD versus staying in
the occupation.
• Proportion of participants satisfied with the products given
(cosmetic, preventive, therapeutic properties of the products).
• Other adverse outcomes: those that are not severe enough
to warrant participants to leave the study (e.g. mild irritation or
other complaints about products applied in the studies).
Search methods for identification of studies
We aimed to identify all relevant RCTs regardless of language
or publication status (published, unpublished, in press, or in
progress).
Electronic searches
For this update, we revised all the search strategies in line with
current Cochrane Skin practices. Details of the previous search
strategies are available in Bauer 2010.
We searched the following databases up to 17 January 2018:
• the Cochrane Skin Specialised Register, using the search
strategy in Appendix 1;
• the Cochrane Central Register of Controlled Trials
(CENTRAL; 2017, Issue 12) in the Cochrane Library, using the
strategy in Appendix 2;
• MEDLINE via Ovid (from 1946), using the strategy in
Appendix 3; and
• Embase via Ovid (from 1974), using the strategy in
Appendix 4.
Trials registers
We searched the following trials databases up to 22nd January
2018:
• the ISRCTN registry (www.isrctn.com), using the search
terms: (Occupational OR contact OR irritant OR prevention)
AND (“hand dermatitis” OR “hand eczema”) OR OIHD;
• ClinicalTrials.gov (www.clinicaltrials.gov), using the search
terms: (Occupational OR contact OR irritant OR prevention)
AND (“hand dermatitis” OR “hand eczema”) OR OIHD;
• the Australian New Zealand Clinical Trials Registry (
www.anzctr.org.au), using the search terms: (Occupational OR
contact OR irritant OR prevention) AND (hand dermatitis OR
hand eczema) OR OIHD;
• the World Health Organization International Clinical Trials
Registry Platform (ICTRP) (apps.who.int/trialsearch/), using the
search terms: occupational AND hand dermatitis OR contact
AND hand dermatitis OR irritant AND hand dermatitis OR
occupational AND hand eczema OR contact AND hand eczema
OR irritant AND hand eczema OR OIHD OR hand eczema
AND primary prevention; and
• the EU Clinical Trials Register (
www.clinicaltrialsregister.eu), using the search terms: hand
eczema OR hand dermatitis.
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Searching other resources
Searching reference lists
We checked the bibliographies of included studies for further ref-
erences to relevant trials.
Unpublished literature
One review author (AB) searched the following dermatology con-
ference proceeding abstracts from 1999 up to January 2018:
• Arbeitsgemeinschaft Berufs und Umweltdermatologie; and
• American Contact Dermatitis Society.
Data collection and analysis
Selection of studies
For the first published review version (Bauer 2010), one review au-
thor (AB) checked titles and abstracts identified from the searches.
Two review authors, AB and Jochen Schmitt (co-author of the
first published review version), independently assessed the full-
text versions of all possibly relevant studies. Two review authors
(AB, JSch) decided which studies met the inclusion criteria, and
recorded their methodological quality. The review authors (AB,
JSch) resolved any disagreement by discussion. One review author
(AB) attempted to obtain missing information from the trial re-
ports by contacting the study investigators.
For the update, four review authors (HR, PE, AB,HCW) checked
titles and abstracts identified in the updated searches. Two review
authors (HR, PE) independently assessed the full-text versions of
all possibly relevant studies and three review authors (AB, PE,HR)
decidedwhich studiesmet the inclusion criteria. Any disagreement
was resolved in discussion. One review author (HR) attempted to
obtain missing information from the trial reports by contacting
the study investigators.
Data extraction and management
For the first published review version, two review authors (AB,
JSch) performed the data extraction and a third (HCW) resolved
discrepancies (Bauer 2010). We slightly modified and then pilot-
tested the Cochrane Skin data collection form for intervention
reviews (Version 3, April 2014) for the extractions.
Two review authors (HR, JL) independently extracted data from
studies which were added during the update and reviewed by three
authors (DD, MLS, AB). We resolved all discrepancies through
discussion (HR, AB, JL, DD, MLS) and a consensus was reached.
We entered data into Cochrane Review Manager 5.3 software for
data management and analysis (RevMan 2014).
Assessment of risk of bias in included studies
In the quality assessment we evaluated the components listed be-
low for each included study, since there is some evidence that these
are associatedwith biased estimates of treatment effect (Juni 2001).
Two authors (AB, JSchm) independently assessed the risk of bias
in the four studies included in the first published version of the
review, according to the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions version 5.0.0 (Higgins 2008).
For this update, one author (HR) re-assessed these as described in
the Cochrane Handbook for Systematic Reviews of Interventions ver-
sion 5.1.0 (chapter 8) (Higgins 2011). Two review authors (HR,
DD) independently assessed the four newly included studies. One
newly included trial was independently assessed by two authors
(HR, AB) (Brüning 2008). We used the criteria listed below and
categorised the studies’ risk of bias as ’low’, ’high’, or ’unclear’ for
each domain.
• Random sequence generation (selection bias)
• Allocation concealment (selection bias)
• Blinding of participants and personnel (performance bias):
lack of blinding possibly influences the proportion of OIHD or
the other outcomes, but there is insufficient information to judge
whether this is likely. The bias risk of studies which did not blind
participants or key personnel was therefore judged as ’unclear’
for all outcomes.
• Blinding of outcome assessment (detection bias): lack of
blinding is considered to introduce:
◦ a low risk of detection bias for the objectively
measured secondary outcome 2 (TEWL and/or corneometry)
◦ a high risk of detection bias for all other outcomes,
which were subjectively assessed.
• Incomplete outcome data (attrition bias) was assessed
separately for the following outcome groups. (When attrition
was low or reasons for loss to follow-up were unlikely to be
related to the outcome, we judged the risk as ’low’; when
attrition was considerable and reasons for loss to follow-up were
likely to be related to the outcome, we judged the risk as ’high’;
when in doubt whether or not reasons for missing were likely to
be related to the outcome, we judged the risk as ’unclear’.)
◦ Outcomes related to signs and symptoms of hand
eczema (primary outcome 1 and 2, secondary outcomes 1, 2, 3,
and 5)
◦ Secondary outcome 4 (proportion of participants
satisfied with the products given (cosmetic, preventive,
therapeutic properties of the products))
• Selective reporting (reporting bias): we judged the risk as
’low’ only if a protocol or other convincing text was available.
We resolved all discrepancies through discussion (HR, DD, MLS,
AB; with advice from CB) and reached consensus.
Measures of treatment effect
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For measuring of treatment effect we used risk ratios (RRs) and
corresponding 95% confidence intervals (CIs). Where possible
we calculated RR (95% CI) from the information given in the
trial papers. The risk ratio can easily be interpreted as the risk
of developing OIHD in the intervention group compared to the
control group. For continuous outcomes, we planned to calculate
mean difference (MD and 95% CI). Where we were unable to
performmeta-analyses, we reported the results from the individual
trials.
Unit of analysis issues
When no correction for cluster randomisation was performed by
the study investigators, we tried to retrieve the necessary data and
calculated the intraclass correlation coefficients (ICCs) and cor-
responding design effects. We divided numbers from such trials
(number of participants, number of events) by the design effect
before including them in the meta-analysis. When study inves-
tigators neither performed corrections for cluster randomisation
nor provide the requested data, we searched the literature for ap-
propriate ICC estimates and performed a Sensitivity analysis.
Studies with split-body or cross-over designs may only report their
data as if they were derived from a parallel design (Higgins 2011
section 16.4.5 and 9.3.8). This can introduce unit-of-analysis is-
sues because confidence intervals for such trials are likely to be too
wide and the studies receive too little weight in meta-analyses. It
is controversial how serious these issues are (Higgins 2011 section
16.4.5). When the data required to include a paired analysis in
a meta-analysis were not given, we included them as if they were
not paired and conducted a Sensitivity analysis that excluded these
trials.
Dealing with missing data
We did not perform any intention-to-treat (ITT) calculations and
missing data were dealt with descriptively (see Characteristics of
included studies: attrition bias).
Concerning studies that did not report primary intervention data
or other crucial information, two review authors (AB, HR) ob-
tained missing data from the study investigators where possible.
Assessment of heterogeneity
We assessed statistical heterogeneity in the studies’ results concern-
ing OIHD using the I² statistic (Higgins 2011).
We commented on clinical and methodological diversity - in-
cluding diagnostic criteria for OIHD (degree of certainty for the
diagnosis of OIHD), scoring system for the severity of OIHD,
and quality of bioengineering methods - in the appropriate
sections (Included studies; Effects of interventions; Discussion;
Characteristics of included studies) (Pinnagoda 1990).
Assessment of reporting biases
The Cochrane Handbook for Systematic Reviews of Interventions
states that ’reporting biases arise when the dissemination of re-
search findings is influenced by the nature and direction of results’
(Higgins 2011). We tried to minimise reporting bias by exten-
sive searching of online databases, etc. (see Search methods for
identification of studies).
We could not use funnel plots due to the small number of the in-
cluded studies, varying interventions and varying methods to de-
termine the main review outcome OIHD across studies (Higgins
2011 chapter 10.4.3.1). Funnel plot assessment of reporting bias
will only be used in future if the number of included studies in-
creases at subsequent updates of this review.
Data synthesis
We always used outcome data from the last follow-up time point.
When meta-analysis was possible, we assessed risk ratio (RR) and
corresponding 95% confidence interval (95% CI) applying the
Mantel-Haenszel method in a random-effects model for dichoto-
mous outcomes. For continuous outcomes we had planned to cal-
culate the standardised mean difference.
Due to the small number of studies, we pooled trials without
accounting for their risk of bias; the risk was addressed in the risk
of bias tables (Risk of bias in included studies) and in the results
section (Characteristics of included studies).
In studies withmore than two arms, we used the control groups for
several comparisons but never double-counted within one com-
parison of interventions.
Whenever we had identified insufficient comparable trials to per-
form meta-analyses, we described these outcomes by a narrative
approach.
Subgroup analysis and investigation of heterogeneity
We were not able to conduct the subgroup analyses that we had
planned (subgrouping according to less than, and greater than 30
years of age; sex; atopy; and occupation). See Differences between
protocol and review for more details.
Sensitivity analysis
We excluded each trial with potential Unit of analysis issues (un-
corrected cluster design, no paired analysis of data from cross-over
or split-body designs) for the sensitivity analyses in order to assess
whether or not the findings were robust to these issues. For cases
where an uncorrected cluster-randomised trial had an impact on
whether or not significance was reached, we planned to calculate
a critical design effect and corresponding ICC, above which over-
all significance would be reached. Correcting for cluster-randomi-
sation reduces a study’s effective sample size in a meta-analysis
(Higgins 2011 chapter 16.3.4). The assessment of a critical ICC
is based on the assumption that with rising ICC (and therefore
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reduced sample size), a study’s impact on the meta-analysis will
drop. The relation is to a minor degree subject to rounding errors.
Another issue was the measurement of the first primary outcome
(proportion of participants developing any signs and symptoms of
OIHD). We excluded all trials that reported signs of hand eczema
instead of manifest hand eczema in the sensitivity analyses in order
to evaluate whether this was influential on the overall results.
’Summary of findings’ tables
We chose two key outcomes (signs and symptoms ofOIHD, treat-
ment discontinuation due to adverse effects) as important for de-
cision making, and presented them in our ’Summary of findings’
tables. We assessed the quality of the evidence for these outcomes
using GRADEproGDT software (GRADEpro GDT 2015). In
the GRADE system, evidence derived from RCTs, as in this re-
view, receives a high quality of evidence rating, but the quality can
be downgraded due to weaknesses in the following domains: risk
of bias, indirectness of evidence, inconsistency of evidence, impre-
cision of the estimated effect, or publication bias (Schünemann
2013). We described the rationale for downgrading in the foot-
notes of the respective tables.
R E S U L T S
Description of studies
Results of the search
We combined the results of the searches for this update with those
from the searches for the last published version of this review.
We identified a total of 1845 records through the database searches
(after removing duplicates). We identified six additional records
through other sources (including reference lists), giving a total
of 1851 results. We excluded 1798 records based on titles and
abstracts.
We assessed 53 records in full text. Of these, we excluded 34
(see Characteristics of excluded studies). We categorised two
further studies (reported in three references) as ongoing (see
Characteristics of ongoing studies) and one study is awaiting clas-
sification (reported in one reference) (see Characteristics of studies
awaiting classification).
Nine studies (described in 15 records), met the review inclusion
criteria andwere included (see Characteristics of included studies).
Five of these were new to this update. We included a total of seven
studies in the meta-analyses.
For a full description of the screening process see our study flow
diagram (Figure 1).
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Figure 1. Study flow diagram including all previous searches.
Included studies
Our searches of electronic databases identified nine randomised
controlled trials (RCTs), with a total of 2888 initially healthy
participants, which met the inclusion criteria (Brüning 2008;
Duca 1994; Flyvholm 2005; Goh 1994; Halkier-Sørensen 1993;
Kütting 2010; Löffler 2006;Meer 2015; Perrenoud 2001a). Please
see Characteristics of included studies for more details of the trial
conditions and ’Risk of bias’ assessments for each study. Five stud-
ies were funded by official funding sources: German metal co-
operative union (Vereinigung der Metall-Berufsgenossenschaften
VMBG); Danish Ministry of Health; Danish Insurance Associ-
ation, Copenhagen, L. P. Hansen’s fund, Odense, and Danfoss
A/S, Nordborg, Denmark; German Statutory Accident Insurance
(DGUV) and the Franz-Koelsch-Stiftung e.V.; NetherlandsOrga-
nization for Health Research and Development (ZONMW). One
study was funded by industry (Asche Chiesi GmbH, Hamburg,
Germany) and three studies did not report any funding sources.
Design
All of the nine included studies were randomised controlled trials.
With the exception of two cross-over studies (Halkier-Sørensen
1993; Perrenoud 2001a), the studies had a parallel design. Four
parallel studies were cluster-randomised (Flyvholm 2005; Kütting
2010; Löffler 2006; Meer 2015). All of these were analysed by
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the study investigators on the individual level without account-
ing for the clustering and without reporting intraclass correla-
tion coefficients (ICCs). This introduces over-precise results with
standard errors and P values which are too small (Higgins 2011).
The comparability of such studies to individually randomised
studies is compromised (Brüning 2008; Duca 1994; Goh 1994;
Halkier-Sørensen 1993; Perrenoud 2001a). For the data from
Meer 2015, we calculated an ICC of 0.005 and a corresponding
design effect of 1.0989, based on data provided by the study in-
vestigators.
Additionally to the individual randomisation to two parallel study
groups, one study randomised the participants’ hands to the inter-
ventions in a second step, thus creating four study arms (Brüning
2008). This design introduces a minor unit of analysis issue and
possibly also contamination effects.
Most of the included studies had two arms, while one was a three-
armed trial (Goh 1994), and two had four arms (Brüning 2008;
Kütting 2010).
We could not include the two cross-over studies, Perrenoud 2001a
and Halkier-Sørensen 1993, in the meta-analyses of the first pri-
mary outcome because they did not report evaluable quantita-
tive data. One reported only scores and no dichotomised data
(Perrenoud 2001a), while the other reported the required data
only for the no-treatment period (Halkier-Sørensen 1993).
Sample sizes
A total of 2888 participants were evaluable for this review (healthy
at the beginning of the study, not lost to follow-up). Most studies
reported some attrition and some studies also recruited partici-
pants with existing occupational irritant hand dermatitis (OIHD).
The numbers of participants who were excluded or lost to follow-
up are given in the Characteristics of included studies tables.The
sample sizes varied from 16 to 893 participants in the individual
trials.
The sample sizes reported throughout the review text do not nec-
essarily refer to the actual number of participants that were eli-
gible for evaluation. In order to correct for cluster design in the
meta-analyses, a reduced ’effective sample size’ (Higgins 2011, sec-
tions 16.3.4 and 16.3.5) was estimated for the respective stud-
ies. The sample sizes of natural participants are reported in the
Characteristics of included studies tables.
Participants and setting
Exclusively healthy participants were recruited for five studies
(Brüning 2008;Goh1994;Halkier-Sørensen 1993;Kütting 2010;
Perrenoud 2001a). Four studies (Duca 1994; Flyvholm 2005;
Löffler 2006; Meer 2015) also recruited workers who were suffer-
ing fromOIHD at the beginning of the study, but data for initially
healthy participants was available.
Three studies (Goh 1994; Löffler 2006; Perrenoud 2001a) in-
cluded only apprentices or newly employed workers. The mean
age of participants in these trials ranged from 18 to 22 years. In the
remaining studies (Brüning 2008; Duca 1994; Flyvholm 2005;
Halkier-Sørensen 1993; Kütting 2010; Meer 2015) the mean age
ranged from 32 to 41 years.
Two trials included exclusively male workers (Brüning 2008;
Kütting 2010). In three trials the majority of participants was
male (65% to 92%) (Duca 1994; Flyvholm 2005; Goh 1994),
and in the remaining trials the majority was female (78% to 99%)
(Halkier-Sørensen 1993; Löffler 2006; Meer 2015; Perrenoud
2001a).
All nine included studies were field studies in occupations prone to
OIHD. The studies dealt with different occupations and different
stages of experience:
• metal workers (Brüning 2008; Goh 1994: newly employed;
Kütting 2010);
• dye and print industry workers (Duca 1994);
• gut cleaners in swine slaughterhouses (Flyvholm 2005);
• cleaners and kitchen assistants (Halkier-Sørensen 1993);
• hospital employees (Löffler 2006: 1st year nurse
apprentices; Meer 2015);
• apprentice hairdressers (Perrenoud 2001a).
Eight trials were performed in the following European countries:
Denmark (Halkier-Sørensen 1993; Flyvholm 2005); Germany (
Brüning 2008; Kütting 2010; Löffler 2006); Italy (Duca 1994);
Netherlands (Meer 2015); Switzerland (Perrenoud 2001a). One
trial was performed in Singapore (Goh 1994).
Interventions
The duration of the interventions was between four weeks and
three years. The participants of five studies received barrier creams,
also called skin protection creams (Brüning 2008; Duca 1994;
Goh 1994; Kütting 2010; Perrenoud 2001a).
• In Duca 1994, the barrier creams were provided by the
employer, were applied twice per day for 12 months, and fell into
two main groups: silicone or hydrocarbon containing barrier
creams.
• In Brüning 2008, the participants received skin protection
(Travabon or Stoko Protect), skin care (Estolan), both, or no
product for 12 months. The products were applied to one hand
while using a glove for the other hand. Further requirements for
the application were not described.
• In Goh 1994, 54 healthy, newly employed metal workers
exposed to cutting fluids were randomised to apply a barrier
cream, to apply a moisturiser, or to the control group for six
months. The barrier cream (Arretil) was used on the hands
before work and after each meal break. The moisturiser (Keri
Lotion) was used daily as an after-work emollient.
• In Kütting 2010, the volunteers received skin protection,
skin care, both, or no recommendation for 12 months. All
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participants used the skin care and protection products that were
provided by the employer. Barrier creams were used before or
during working hours. Skin care products were applied solely
after work.
• In Perrenoud 2001a, the participants started either with a
barrier cream (Excipial protect) or with its vehicle. Excipial
protect contains aluminium hydroxychloride and glycerine; the
vehicle was designed specifically for skin care for occupational
users. The first cream was applied five days per week for two
weeks with a washout period of two days followed by another
two-week treatment period with the second cream and vice versa.
In four studies, the participants received moisturiser, also called
skin care creams or emollients. Three of them are described above
because they also investigated the effects of barrier creams (Brüning
2008; Goh 1994; Kütting 2010).
• In Halkier-Sørensen 1993, the participants were randomly
allocated to two cross-over groups for two lots of two weeks. One
group started with a moisturiser (Locobase); the other group
started with no treatment. Application requirements were not
described.
Three studies implemented skin protection education pro-
grammes (Flyvholm 2005; Löffler 2006;Meer 2015), which could
include providing products (Löffler 2006; Meer 2015). All three
educational programmes advised the participants to substitute
hand washing with alcohol-based hand disinfection when there
is no visible contamination, to wear gloves appropriately, and to
apply skin care creams.
• In Flyvholm 2005, a prevention programme (skin
protection education) was evaluated for 12 months. The
prevention strategy consisted of a two-part concept, with an
evidence-based prevention programme giving recommendations
for prevention of work-related skin problems in wet work
occupations, and a documented method for implementation.
The recommendations were aimed at the management and at the
employees. The local project group included two to five gut
cleaners who acted as role models.
• In Löffler 2006, the intervention group received skin
protection education (educational lecture with practical parts),
and skin care cream (Asche Basis Creme). The cream was also
given to participants in of the control group. The lectures took
place three times in the first year, and twice in the second and
third year.
• In Meer 2015, a multifaceted implementation strategy (skin
protection education) was evaluated for 12 months. The
intervention included participatory working groups, role modes,
an educational programme including reminders, and a leaflet,
while the comparison group received only the leaflet.
Comparisons
The included trials fell in four categories of interventions:
• barrier creams versus no intervention (Brüning 2008; Duca
1994; Goh 1994; Kütting 2010);
• moisturisers versus no intervention (Brüning 2008; Goh
1994; Kütting 2010);
• combination of barrier creams and moisturisers versus no
intervention (Brüning 2008; Kütting 2010);
• skin protection education versus no or minimal
intervention (Flyvholm 2005; Löffler 2006; Meer 2015).
We identified no trials which used the remaining predefined types
of interventions (protective gloves; complex interventions using
barrier creams, moisturisers, and protective gloves).
Outcomes
This section describes how the review outcomes were reported in
the included studies. For results, see Effects of interventions.
Primary outcome 1: the proportion of participants
developing any signs and symptoms of OIHD (incident
cases) measured by clinical scores (IGA) and/or hand
dermatitis scores (e.g. HECSI, Manuscore) as rated by the
investigator (physician/nurse) or the participant
None of the included studies used the term OIHD. We decided
that the following outcomes were eligible as primary review out-
come 1:
• hand eczema (Flyvholm 2005; Halkier-Sørensen 1993;
Kütting 2010; Meer 2015);
• abnormal morphology (Brüning 2008: ’klinischer
Hautbefund’; Duca 1994: ’esame obiettivo positivo per uno o
più dei segni’; Löffler 2006: ’Morphologie auffällig’);
• cutting fluid dermatitis (Goh 1994).
One study applied scores for measuring skin damage and did not
dichotomise their data (Perrenoud 2001a), so that no proportion
could be extracted.
The outcome was assessed by the study personnel except for three
studies (Flyvholm 2005; Kütting 2010; Meer 2015), in which the
participants reported hand eczema in standardised interviews.
The proportion was reported as point prevalence at last follow-
up (Brüning 2008; Halkier-Sørensen 1993), period prevalence of
the last three or six months (Flyvholm 2005; Kütting 2010; Meer
2015), or as proportion of participants with signs of OIHD at
either follow-up (Duca 1994; Goh 1994; Löffler 2006).
Primary outcome 2: frequency of treatment discontinuation
due to adverse effects
In one cross-over study (Halkier-Sørensen 1993), this outcome
was addressed to some extent, while in some others it was evident
from the dropout analyses that no participant was lost to follow-
up because of adverse effects (Brüning 2008; Goh 1994; Löffler
2006).
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Secondary outcome 1: severity of clinical signs and
symptoms in incident cases of OIHD (measured by clinical
scores (IGA) or hand dermatitis scores (e.g. HECSI,
Manuscore), or both, as rated by the investigator
(physician/nurse) or the participant
Some studies applied scores (Halkier-Sørensen 1993; Kütting
2010; Meer 2015; Perrenoud 2001a), but they were not reported
separately for incident cases of OIHD.
Secondary outcome 2: proportion of participants with
significant changes (difference in average score or difference
from baseline, or both) in barrier function or hydration,
measured using transepidermal water loss (TEWL), and
corneometry (skin hydration)
TEWL was reported in three studies (Brüning 2008; Goh 1994;
Halkier-Sørensen 1993), but in Brüning 2008, quartiles were
given instead of mean and standard deviation. Only figures were
provided in Halkier-Sørensen 1993.
Skin hydration was assessed in two studies (Brüning 2008;
Halkier-Sørensen 1993). One study assessed TEWL, corneome-
try, and chromometry (measurement of colour), but did not re-
port their results (Perrenoud 2001a).
Secondary outcome 4: proportion of participants satisfied
with the products given (cosmetic, preventive, therapeutic
properties of the products)
Two studies addressed the participants’ opinion on the products
(Halkier-Sørensen 1993; Perrenoud 2001a).
Secondary outcome 5: other adverse outcomes: those that are
not severe enough to warrant participants to leave the study
(e.g. mild irritation or other complaints about products
applied in the studies)
Two studies described this outcome (Halkier-Sørensen 1993;
Perrenoud 2001a).
Excluded studies
We excluded 20 studies that may have been expected to be in-
cluded. Of these, 11 were RCTs, eight were controlled clinical tri-
als (CCTs), and one was a qualitative study.
Reasons for excluding the RCTs are as follows.
• We excluded three studies because they violated the
inclusion criteria by exclusively including workers suffering from
OIHD and therefore dealing with secondary prevention not with
primary prevention of OIHD (Arbogast 2004; Berndt 2000;
McCormick 2000).
• We excluded Held 2002, because some workers who
already had hand dermatitis at baseline (’skin problems’: 25% to
30%) participated. The study investigators responded that
providing the required data for initially healthy participants
would be too difficult because the study was conducted almost
15 years ago. The study investigators of another trial, Winker
2009, replied that they would not provide the requested data
because they feared the power would be too low if participants
with OIHD at baseline were removed from the sample size. We
were unable to contact the study investigators of Frosch 2003,
which did not provide sufficient information about hand
dermatitis at baseline. Furthermore, the design of this trial
showed weaknesses: only five laboratories were randomised to
four products; and it used only a partial cross-over-design (two
out of four products were tested in the same laboratory). In this
update we were able to include two studies which had previously
been excluded, after the study investigators provided the
requested data (Flyvholm 2005; Löffler 2006).
• We excluded Perrenoud 2001b, which investigated
protective cream versus no intervention, because only
preliminary data (no quantitative data) were available on OIHD
and it was unclear if participants with existing OIHD were
included. One study did not address the prevention of OIHD
and did not report data on OIHD or any other review outcome
(Mody 2003). We excluded another study, Winnefeld 2000,
because its interventions (non-medicated soap versus an alcohol-
based hand rinse) were not defined as interventions to prevent
OIHD according to this review. Furthermore, the trial only took
eight days and the incidence of OIHD was not assessed. We
excluded another study, Dobson 1979, because it examined the
effect of industrial hand cleansers, an intervention that was not
considered in this review, and there was no data on OIHD.
Their only outcome was TEWL. The only study concerning
protective glove use was excluded because it was performed in an
experimental setting (Davis 2005).
We excluded seven controlled clinical trials because they were not
randomised (Amphoux 1975; Bauer 2002; Bolam 1971; Bregnhøj
2012; Held 2001; Schwanitz 2003; Sell 2005). We also excluded
Glantz 1976, because it was probably not randomised and no
relevant outcome data was assessed.
We excluded one study, Brown 2007, because for the most part
it was a qualitative study (intervention implementation research)
and it did not provide sufficient data on OIHD for the different
interventions.
Risk of bias in included studies
A summary of the ’Risk of bias’ assessments, which we carried
out for each included study, can be seen in Figure 2 and Figure
3. Details can be found in the Characteristics of included studies
tables.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Figure 3. ’Risk of bias’ graph: review authors’ judgements about each ’Risk of bias’ item presented as
percentages across all included studies.
Allocation
Most studies did not provide any information on allocation except
that it was at random, and we judged the risk of bias as unclear
in these cases. Allocation concealment was not mentioned in any
study; we therefore judged the risk of bias for this domain as
unclear, except for inKütting 2010. The risk of bias in this trial was
high because potential confounders were significantly unbalanced
at baseline.
Blinding
We judged the risk of performance bias as unclear for all four
studies which did not blind the workers, and for four studies with
unclear blinding. Only two studies reported blinding their partic-
ipants (Meer 2015; Perrenoud 2001a).
In five studies, the outcome assessors were blinded, so we judged
them as having a low risk of detection bias (Brüning 2008; Duca
1994; Löffler 2006;Meer 2015; Perrenoud 2001a). For one study,
we judged the risk of bias as high because the outcome assessors
were not blinded (Flyvholm 2005). Three studies probably did not
blind the outcome assessors and so we judged them as having an
unclear risk of bias for this domain (Goh 1994; Halkier-Sørensen
1993; Kütting 2010).
Incomplete outcome data
Three trials had a low risk of attrition bias (Brüning 2008; Goh
1994; Löffler 2006). The risk of attrition bias was high in one
study (Halkier-Sørensen 1993). For five studies, the risk of bias
was unclear because there was there was no dropout analysis or the
analysis did not provide the information required for the risk of
bias assessment (Duca 1994; Flyvholm 2005; Kütting 2010;Meer
2015; Perrenoud 2001a).
Selective reporting
We assessed most trials as having an unclear risk of reporting
bias, because the study protocols were not available. One study,
Meer 2015, reported the predefined outcomes so we assessed
this study as having a low risk of reporting bias. Another study,
Halkier-Sørensen 1993, did not report their results according to
the original randomisation, but according to the ability of the
participants to complete the study period. Thus, the results were
not reported in a way appropriate for an RCT, so we assigned a
judgement of high risk of bias. They did not provide any data on
OIHD that may have been used in the meta-analysis.
Other potential sources of bias
In three of the four cluster-randomised trials, no correction for the
design effect was applied (Flyvholm 2005; Kütting 2010; Löffler
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2006). They were analysed on the individual level without ac-
counting for the clustering. This does not lead to a biased estimate
of effect but it introduces over-precise results with too small stan-
dard errors and P values (Higgins 2011). The comparability to
individually randomised studies is therefore compromised. Data
from one trial, Kütting 2010, was used in the meta-analyses of the
effect of barrier creams or moisturisers (or both) on OIHD (com-
parisons 1, 2, 3). All three studies included in the meta-analysis of
educational programmes (comparison 4) were cluster-randomised
trials.
Baseline imbalances introduced a high risk of bias to two stud-
ies (Flyvholm 2005; Halkier-Sørensen 1993). They introduced an
unclear risk of bias in three studies (Duca 1994: insufficient infor-
mation; Goh 1994; Perrenoud 2001a: insufficient information).
One study reported a possible, unclear bias introduced through
differential diagnostic activity across study groups (Meer 2015).
Apart from these exceptions, there was a low risk of bias concern-
ing design, baseline imbalances, funding sources, and blocked ran-
domisation. For three remaining studies, all these possible risks of
bias were low (Brüning 2008; Kütting 2010; Löffler 2006).
Effects of interventions
See: Summary of findings for the main comparison Barrier
creams compared to no treatment for preventing occupational
irritant hand dermatitis; Summary of findings 2 Moisturisers
compared to no treatment for preventing occupational irritant
hand dermatitis; Summary of findings 3 Barrier creams
and moisturisers compared to no treatment for preventing
occupational irritant hand dermatitis; Summary of findings
4 Skin protection education compared to no or minimal
intervention for preventing occupational irritant hand dermatitis
We performed four meta-analyses for the main outcome, propor-
tion of participants developing signs or symptoms of occupational
irritant hand dermatitis (OIHD), with up to four trials for each
type of intervention.
For details on clinical and methodological diversity of the pooled
studies, see Characteristics of included studies.
Studies relevant to this review fall into four comparisons. In total
there were nine relevant randomised studies.
Comparison 1: barrier creams versus no treatment
or vehicle
Four trials compared barrier creams against no treatment (Brüning
2008; Duca 1994; Goh 1994; Kütting 2010), while one study
compared a protection cream against its vehicle (Perrenoud
2001a).
1.1 Primary outcome 1: the proportion of participants
developing any signs and symptoms of OIHD (incident
cases) measured by clinical scores (IGA) or hand dermatitis
scores (e.g. HECSI, Manuscore), or both, as rated by the
investigator (physician/nurse) or the participant
We identified four studies relevant to this outcome (total number
of participants (N) = 999). The trials investigated metal workers
exposed to cutting fluids (almost exclusively male) or dye/print
factory workers. The duration was between six and 12 months.
Except for Brüning 2008, all trials showed a slightly reduced risk
of developing OIHD when applying barrier creams. In the in-
tervention groups, 29% of participants developed symptoms of
OIHD, compared to 33% in the control groups. However, when
these data were pooled, the wide confidence intervals were consis-
tent with either a reduced risk or no effect (risk ratio (RR) 0.87,
95% confidence interval (CI) 0.72 to 1.06; P = 0.18), and the
quality of the evidence was low (Summary of findings for themain
comparison). Across the individual studies, the RR ranged from
0.51 to 1.29, but the I2 measure showed no substantial hetero-
geneity (I2 = 9%) (Analysis 1.1).
Sensitivity analysis
The results of the sensitivity analyses are shown in Table 1. When
we removed Kütting 2010, a cluster-randomised trial, from the
meta-analysis, the confidence intervals were still wide and included
no effect. We deduced that correcting for cluster randomisation
in this study would still yield no significant results.
There was another unit-of-analysis issue since one study, Brüning
2008, had a partial split-body design. The hands that were ran-
domised to the barrier cream belonged to the same individuals as
the hands randomised to the control arm. When we excluded this
study from the analysis, the relative risk was marginally lower, and
the confidence intervals only just included no effect. Apart from
the unit-of-analysis issue, contamination between the two study
arms may have obliterated the preventive effect in this study.
Including only studies with the outcome hand eczema or hand
dermatitis showed a greater effect, but the confidence intervals
were still wide and included no effect.
Overall the sensitivity analyses revealed that the findingswere quite
robust concerning unit-of-analysis and measures-of-effect issues.
Other data
One study could not be pooled with other trials (Perrenoud
2001a). It found that the barrier cream (Excipial protect) and its
vehicle, used for five days a week for two weeks, were similarly
protective.Most participants developed no or mild symptoms.We
could not estimate RR or score values because no quantitative data
were reported by the study investigators.
1.2 Primary outcome 2: frequency of treatment
discontinuation due to adverse effects
In two studies, it was evident from the dropout analyses that no
participantwas lost to follow-upbecause of adverse effects from the
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barrier creams (Brüning 2008; Goh 1994). In one further study,
dropout reasons were unrelated to the trial (Perrenoud 2001a).
However, we cannot fully exclude the possibility that some of the
participants who completed these studies may have stopped apply-
ing the products without the researchers’ knowledge. In two stud-
ies, dropout analyses were not performed or not detailed enough
to extract whether or not adverse effects were among the reasons
for dropout (Kütting 2010; Duca 1994). The numbers of partic-
ipants who dropped out of the individual trials ranged from 0%
to 24% and are given in the Characteristics of included studies
tables.
1.3 Secondary outcome 1: severity of clinical signs and
symptoms in incident cases of OIHD (measured by clinical
scores (IGA) or hand dermatitis scores (e.g. HECSI,
Manuscore), or both) as rated by the investigator
(physician/nurse) or the participant
Two studies applied scores (Kütting 2010; Perrenoud 2001a), but
theywere not reported separately for incident cases ofOIHD.One
study reported the follow-up proportions ofOIHD in participants
with OIHD at baseline, but they did not report any scores (Duca
1994). Two studies did not address this outcome (Brüning 2008;
Goh 1994).
1.4 Secondary outcome 2: proportion of participants with
significant changes (difference in average score or difference
from baseline, or both) in barrier function or hydration,
measured using trans epidermal water loss (TEWL) (skin
barrier) and corneometry (skin hydration)
TEWL
Tewl, ameasure of skin barrier function,was reported in three stud-
ies (Brüning 2008; Goh 1994; Perrenoud 2001a), but one study
gave quartiles instead of mean and standard deviation (Brüning
2008), and another only gave figures and P values (Perrenoud
2001a). One study, Goh 1994, reported TEWL only for one time
point but did not clarify for which. We were therefore unable to
pool the data. The TEWL differences in the barrier cream groups
compared to their respective controls were neither clinically im-
portant nor statistically significant in any of the three trials.
In Brüning 2008, the metal workers’ median TEWL after one
year was lower than at baseline in all study arms, including the
control, but the changes were not significant (Table 2). TEWL in
the barrier cream group was somewhat lower at the last follow-up
compared to control (not significant).
InGoh 1994, it remains unclear for which time point basal TEWL
was reported. The values showed no significant differences be-
tween the groups. Results for TEWL analysis were as follows: in
the control group the mean basal TEWL was 16.7 g/m²h while
in the barrier cream group it was 15.5 g/m²h; the mean TEWL
difference between groups was 1.2 g/m²h (not clinically impor-
tant nor statistically significant). Concerning the three trial groups
(barrier cream, moisturiser, control), the trial investigators found
that changes of the metal workers’ TEWL, ’throughout the six-
month study period, were almost identical’.
In Perrenoud 2001a, no important changes in TEWL values were
observed. TEWL increased during barrier cream treatment with-
out reaching statistical significance (Table 3).
Skin hydration
This outcome was assessed in two studies (Brüning 2008;
Perrenoud 2001a), but figures and P values were only provided in
Perrenoud 2001a.
In Brüning 2008, median skin hydration was higher in the barrier
cream group at last follow-up compared to baseline (P = 0.0491,
Table 2). Skin hydration at baseline and after one year in the
intervention group was almost equal to the controls.
In Perrenoud 2001a, skin hydration of apprentice hairdressers
measured by corneometry was significantly higher during the two
weeks of vehicle use (P < 0.01, Table 3) than for the barrier cream.
However, skin hydration was already visibly lower at the beginning
of the verum period compared to the vehicle.
The details of these bioengineering methods are given in the
Characteristics of included studies tables.
1.5 Secondary outcome 3: change of occupation because of
OIHD versus staying in the occupation
None of the trials reported this outcome.
1.6 Secondary outcome 4: proportion of participants
satisfied with the products given (cosmetic, preventive,
therapeutic properties of the products)
Only one study addressed this outcome (Perrenoud 2001a). The
satisfaction with the products was generally high. No difference
was noted between the creams except with regard to texture. The
vehicle was regarded as too oily by 11 out of 16 participants, while
four considered the barrier cream to be too oily. Five participants
did not plan to use the vehicle, two would not use the barrier
cream, and one would not use either again.
1.7 Secondary outcome 5: other adverse outcomes: those
that are not severe enough to warrant participants to leave
the study (e.g. mild irritation or other complaints about
products applied in the studies)
Only one study addressed this outcome. Mild adverse events like
transient reddening and itching (no values reported) after use of
Excipial protect or its vehicle were reported in Perrenoud 2001a.
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Comparison 2: moisturisers versus no treatment
Four trials compared moisturisers against no treatment (Brüning
2008; Goh 1994; Halkier-Sørensen 1993; Kütting 2010).
2.1 Primary outcome 1: the proportion of participants
developing any signs and symptoms of OIHD (incident
cases) measured by clinical scores (IGA) or hand dermatitis
scores (e.g. HECSI, Manuscore), or both, as rated by the
investigator (physician/nurse) or the participant
We identified three studies relevant to this outcome (N=507). The
trials investigated metal workers (almost exclusively male) exposed
to cutting fluids. The duration was between six and 12 months.
All trials showed a reduced risk of developing OIHD when apply-
ing moisturisers. In two individual trials as well as in the pooled
analysis, the risk reduction was clinically important (0.75 or less).
In the intervention groups, 13% of participants developed symp-
toms of OIHD compared to 19% in the control groups. However,
when these data were pooled, the wide confidence intervals were
consistent with either an important effect or no effect (RR 0.71,
95% CI 0.46 to 1.09; P = 0.11) and the quality of evidence was
low (Summary of findings 2). Across the individual studies, RR
ranged from 0.63 to 0.99. The heterogeneity was not substantial
( I2 = 10%) (Analysis 2.1).
Sensitivity analysis
The results of the sensitivity analysis are shown in Table 4. Despite
low heterogeneity, data from the remaining two studies showed a
reduced risk of developing OIHDwhen moisturisers were applied
after removing Brüning 2008. In this comparison, the study by
Brüning and colleagues was the only study which did not define
hand eczema or hand dermatitis as their outcome (it used abnor-
mal morphology instead). Another limitation of this study was the
partial split-body design, which may have introduced contamina-
tion.
When removing Kütting 2010, the confidence intervals were still
very wide and included no effect. We deduced that correcting for
cluster randomisation in this study would still not yield significant
results.
The sensitivity analysis revealed that the findings were robust con-
cerning uncorrected cluster design (Kütting 2010), but the pre-
ventive effect of moisturisers appeared much clearer without data
from Brüning 2008.
Other data
We could not pool one cross-over study with other trials be-
cause no dichotomised data were available for the treatment pe-
riod (Halkier-Sørensen 1993). The study found that cleaners and
kitchen workers often developed signs of OIHD during the two
weeks of the control period: nineteen participants (20.4%) de-
veloped dry eczema, another 15 (16.1%) developed dryness and
scaling, and 38 (40.9%) developed dryness only (N = 93 workers
who completed both periods (group one), or ceased from the con-
trol period prematurely (group two)). For the two-week treatment
period with a moisturiser (Locobase), no such data were reported.
However, a score which summarised severity ratings for several
symptoms of OIHD was significantly reduced after the treatment
period compared to the control period (Wilcoxon test, P < 0.001).
2.2 Primary outcome 2: frequency of treatment
discontinuation due to adverse effects
In two studies it was evident from the dropout analyses that no
participant was lost to follow-up because of adverse effects from
the moisturisers (Brüning 2008; Goh 1994). However, we cannot
fully exclude the possibility that some of the participants who
completed these studies may have stopped applying the products
without the researchers’ knowledge.
In one cross-over study (Halkier-Sørensen 1993), 12 participants
violated the protocol or declined to continue the study because
they developed or feared to develop hand dermatitis during the
no-treatment period. Six participants turned up only once, did not
find Locobase acceptable, or went on vacation. It remains unclear
if some of these discontinued the treatment phase due to adverse
effects. Severe dryness of the skin caused 23 participants (20.7%)
to drop out during the no-treatment phase.
No dropout analyses were performed in Kütting 2010.
The numbers of participants who dropped out of the individual
trials ranged from 0% to 37% and are given in the Characteristics
of included studies tables.
2.3 Secondary outcome 1: severity of clinical signs and
symptoms in incident cases of OIHD (measured by clinical
scores (IGA) or hand dermatitis scores (e.g. HECSI,
Manuscore), or both) as rated by the investigator
(physician/nurse) or the participant
None of the included studies addressed this outcome. Some studies
applied scores (Halkier-Sørensen 1993; Kütting 2010), but they
were not reported separately for incident cases of OIHD.
2.4 Secondary outcome 2: proportion of participants with
significant changes (difference in average score or difference
from baseline, or both) in barrier function or hydration,
measured using TEWL (skin barrier) and corneometry (skin
hydration)
TEWL
TEWL was reported in three studies (Brüning 2008; Goh 1994;
Halkier-Sørensen 1993), but one study gave quartiles instead of
mean and standard deviation (Brüning 2008), and another only
gave figures and P values (Halkier-Sørensen 1993). One study
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reported TEWL only for one time point but did not clarify for
which (Goh 1994). The TEWL differences in the barrier cream
groups compared to their respective controls were neither clinically
relevant nor statistically significant in any of the three trials.
In Brüning 2008, themetal workers’ median TEWL after one year
was lower than at baseline in all study arms, including the control,
but the authors reported that the changes were not significant
(Table 2). There was no important difference between moisturiser
and control at both points in time. For metal workers exposed to
cutting fluids, the application of a moisturiser over one year had
no significant effects on TEWL.
InGoh 1994, it remains unclear for which time point basal TEWL
was reported. The values showed no significant differences be-
tween the groups. Results for TEWL analysis were as follows: In
the control group, the mean basal TEWL was 16.7 g/m²h. In the
moisturiser group, the mean basal TEWL was 15.4 g/m²h (not
statistically significant). Concerning the three trial groups (barrier
cream, moisturiser, control), the study investigators found that
changes of the metal workers’ TEWL, ’throughout the six-month
study period, were almost identical’.
In Halkier-Sørensen 1993, TEWL after the moisturisers period
in was marginally higher compared to the control period (not
significant, Table 5).
Skin hydration
This outcome was assessed in two studies (Brüning 2008;Halkier-
Sørensen 1993), but only one of these gave figures and P values
(Halkier-Sørensen 1993).
In both moisturiser group and controls of Brüning 2008, median
skin hydration was higher at last follow-up compared to baseline
(not significant, Table 2). Skin hydration was marginally lower in
the moisturisers group at baseline and after one year compared to
controls (not significant).
In Halkier-Sørensen 1993, after the no-treatment period, the
cleaners’ and kitchen workers’ skin hydration was considerably
lower compared to the period when they used a moisturiser (P <
0.001, Table 5).
The details of these bioengineering methods are given in the
Characteristics of included studies tables.
2.5 Secondary outcome 3: change of occupation because of
OIHD versus staying in the occupation
None of the trials reported this outcome.
2.6 Secondary outcome 4: proportion of participants
satisfied with the products given (cosmetic, preventive,
therapeutic properties of the products)
Only one study addressed this outcome. In Halkier-Sørensen
1993, 80% of the participants rated the quality of the moisturiser
as good or very good. Thirteen per cent stated that it had no effect.
Two participants did not find Locobase cosmetically acceptable.
No data on adherence were given in that study.
2.7 Secondary outcome 5: other adverse outcomes: those
that are not severe enough to warrant participants to leave
the study (e.g. mild irritation or other complaints about
products applied in the studies)
Only one study addressed this outcome. Itching, stinging, and
dry skin after application of Locobase were reported in 7% of the
participants of the study of Halkier-Sørensen 1993.
Comparison 3: barrier creams and moisturisers
versus no treatment
Four trials compared a combination of barrier creams and mois-
turisers against no treatment (Brüning 2008; Goh 1994; Halkier-
Sørensen 1993; Kütting 2010).
3.1 Primary outcome 1: the proportion of participants
developing any signs and symptoms of OIHD (incident
cases) measured by clinical scores (IGA) or hand dermatitis
scores (e.g. HECSI, Manuscore), or both, as rated by the
investigator (physician/nurse) or the participant
We identified two studies relevant to this outcome (N = 474). Two
studies of male German metal workers were pooled for the meta-
analysis of barrier creams and moisturisers versus no intervention.
The duration was 12 months. Both trials showed a reduced risk of
developing OIHD when applying barrier creams and moisturis-
ers. The risk reduction was clinically important (less than 0.75)
in one individual trial and in the pooled analysis. In the interven-
tion groups, 8% of participants developed symptoms of OIHD
compared to 13% in the control groups, but when the data were
pooled the very wide confidence intervals were consistent with ei-
ther an important effect or no effect (RR 0.68, 95% CI 0.33 to
1.42; P = 0.30) and the quality of evidence was low (Summary
of findings 3). RR ranged from 0.43 to 0.92. This outcome had
moderate levels of heterogeneity (Chi2 = 1.84; df = 1.0; P = 0.17;
I2 = 46%) (Analysis 3.1).
Sensitivity analysis
The results of the sensitivity analysis are shown in Table 6. When
we excluded the trial Brüning 2008, which addressed abnormal
morphology instead of hand eczema and had a partial split-body
design, the remaining study showed a considerable effect but this
did not reach significance.
When we removed Kütting 2010, the effect estimate was still very
imprecise. We deduced that correcting for cluster randomisation
in this study would still yield no significant results.
Because only two trials with moderate statistical heterogeneity
were included in this comparison, the sensitivity analysis showed a
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considerable change in RR but not in statistical significance when
either study was removed.
3.2 Primary outcome 2: frequency of treatment
discontinuation due to adverse effects
In one study it was evident from the dropout analyses that no
participant was lost to follow-up because of adverse effects from
the moisturisers (Brüning 2008). However, we cannot fully ex-
clude the possibility that some of the participants who completed
this study may have stopped applying the products without the
researchers’ knowledge.
No dropout analyses were performed in Kütting 2010.
The numbers of participants who dropped out of the individual
trials ranged from 8% to 24% and are given in the Characteristics
of included studies tables.
3.3 Secondary outcome 1: severity of clinical signs and
symptoms in incident cases of OIHD (measured by clinical
scores (IGA) or hand dermatitis scores (e.g. HECSI,
Manuscore), or both) as rated by the investigator
(physician/nurse) or the participant
None of the included studies addressed this outcome. One study
applied scores (Kütting 2010), but they were not reported sepa-
rately for incident cases of OIHD.
3.4 Secondary outcome 2: proportion of participants with
significant changes (difference in average score and/or
difference from baseline) in barrier function or hydration,
measured using TEWL (skin barrier) and corneometry (skin
hydration)
TEWL
TEWL was reported in one study (Brüning 2008). The study in-
vestigators gave quartiles instead of mean and standard deviation.
The metal workers’ median TEWL after one year was lower than
at baseline in all study arms, including the control, but the changes
were small and not significant (Table 2). There was no clinically
important difference between barrier creams plus moisturiser and
control at the last follow-up.
Skin hydration
This outcomewas assessed in one study (Brüning 2008). The study
investigators gave quartiles instead of mean and standard devia-
tion. For barrier creams plus moisturiser, median skin hydration
was somewhat higher at last follow-up compared to baseline (P
= 0.0402). Without reaching significance or clinical importance,
skin hydration was lower in this group at baseline and after one
year.
The details of these bioengineering methods are given in the
Characteristics of included studies tables.
3.5 Secondary outcome 3: change of occupation because of
OIHD versus staying in the occupation
None of the trials reported this outcome.
3.6 Secondary outcome 4: proportion of participants
satisfied with the products given (cosmetic, preventive,
therapeutic properties of the products)
None of the trials reported this outcome.
3.7 Secondary outcome 5: other adverse outcomes: those
that are not severe enough to warrant participants to leave
the study (e.g. mild irritation or other complaints about
products applied in the studies)
None of the trials reported this outcome.
Comparison 4: skin protection education versus no or
minimal intervention
We identified three studies for this comparison.
4.1 Primary outcome 1: the proportion of participants
developing any signs and symptoms of OIHD (incident
cases) measured by clinical scores (IGA) or hand dermatitis
scores (e.g. HECSI, Manuscore), or both, as rated by the
investigator (physician/nurse) or the participant
For this outcome we found three relevant studies. A total num-
ber of 1443 gut cleaners, nurse apprentices, or hospital employ-
ees were included. In order to account for the cluster design in
Meer 2015, the effective sample size needed to be corrected to
a total of 1355 participants. The duration was between one and
three years. With a skin protection education, the risk of devel-
oping OIHD was reduced in two studies (Flyvholm 2005; Löffler
2006). In these two studies, the risk reduction was clinically im-
portant (less than 0.75). One study showed an non-significant but
clinically important increased risk compared to the minimal im-
plementation group (leaflet only) (Meer 2015). When we pooled
these data, the wide confidence intervals were consistent with ei-
ther a reduced risk or no effect (RR 0.76, 95%CI 0.54 to 1.08; P =
0.12) and theGRADE quality of evidence was very low (Summary
of findings 4). In the intervention groups 21% of participants de-
veloped symptoms of OIHD, compared to 28% in the control
groups. RR ranged from 0.69 to 1.26. We observed high levels
of statistical heterogeneity (Chi2 = 4.44; df = 2.0; P = 0.11; I2 =
55%) (Analysis 4.1).
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Sensitivity analysis
The results of the sensitivity analysis are shown in Table 7. All
three trials were cluster-randomised and only the authors of one
study provided the data required for the correction of the design
effect (Meer 2015). After removing Flyvholm 2005, the effect was
still very imprecise and the CI included 1. The same was true for
removing Löffler 2006, or both trials, from the meta-analysis. We
deduced that correcting for cluster randomisation in these two
studies would still yield no significant results. Only one study in
this comparison did not measure hand eczema or hand dermatitis,
but instead measured morphological changes (Löffler 2006).
The risk reduction appeared considerably smaller when either or
both studies with uncorrected cluster design were removed. One
partial reason for this is that uncorrected cluster designs often
show an artificially greater effect. Another reason is that the only
study without unit-of-analysis issues showed a negative effect of
skin protection education. The study authors speculate that this
was the case because the participants of their intervention group
were more aware of hand dermatitis due to the education and may
have reported it more often only due to this awareness.
4.2 Primary outcome 2: frequency of treatment
discontinuation due to adverse effects
In one study it was evident from the dropout analyses that no
participant was lost to follow-up because of adverse effects (Löffler
2006). However, we cannot fully exclude the possibility that some
of the participants who completed the study may have stopped
applying the products without the researchers’ knowledge.
Two studies did not report any dropout reasons (Flyvholm 2005;
Meer 2015).
The numbers of participants who dropped out of the individual
trials ranged from35% to 38% and are given in theCharacteristics
of included studies tables.
4.3 Secondary outcome 1: severity of clinical signs and
symptoms in incident cases of OIHD (measured by clinical
scores (IGA) or hand dermatitis scores (e.g. HECSI,
Manuscore), or both) as rated by the investigator
(physician/nurse) or the participant
None of the included studies addressed this outcome. One study
applied scores (Meer 2015), but they were not reported separately
for incident cases of OIHD
4.4 Secondary outcome 2: proportion of participants with
significant changes (difference in average score or difference
from baseline, or both) in barrier function or hydration,
measured using TEWL (skin barrier) and corneometry (skin
hydration)
None of the trials in this comparison reported these outcomes.
4.5 Secondary outcome 3: change of occupation because of
OIHD versus staying in the occupation
None of the trials in this comparison reported these outcomes.
4.6 Secondary outcome 4: proportion of participants
satisfied with the products given (cosmetic, preventive,
therapeutic properties of the products)
None of the trials in this comparison reported these outcomes.
4.7 Secondary outcome 5: other adverse outcomes: those
that are not severe enough to warrant participants to leave
the study (e.g. mild irritation or other complaints about
products applied in the studies)
None of the trials in this comparison reported these outcomes.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Moisturisers compared to no treatment for preventing occupational irritant hand dermatitis
Patient or population: workers at risk of occupat ional irritant hand dermatit is
Setting: metal factories
Intervention: moisturisers
Comparison: no treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no treatment Risk with moisturisers
The proport ion of
part icipants developing
any signs and symp-
toms of OIHD (incident
cases) measured by
clinical scores (IGA) or
hand dermatit is scores
(e.g. HECSI, Manus-
core), or both, as
rated by the invest iga-
tor (physician/ nurse) or
the part icipant (propor-
t ion of OIHD)
Follow up: range 6
months to 12 months
Study populat ion RR 0.71
(0.46 to 1.09)
507
(3 RCTs)
⊕⊕©©
LOW 1
187 per 1000 133 per 1000
(86 to 204)
Frequency of treatment
discont inuat ion due to
adverse ef fects
Follow up: range 2
weeks to 12 months
All dropout reasons were unrelated to the treatment: the numbers of
part icipants who dropped out of the individual trials ranged f rom 0% to
37%
133
(2 RCTs)
⊕⊕⊕©
MODERATE2
Information only avail-
able f rom dropout anal-
yses, which were not
designed to detect ad-
verse ef fects
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*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI). The risk in the comparison group is based on mean proport ion observed in the comparison groups.
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io; OIHD: occupat ional irritant hand dermatit is
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded by two levels. Downgraded one level for imprecision because the conf idence intervals were wide and included
1 as well as a clinically signif icant relat ive risk (0.75 or less). Downgraded one level for inconsistency because criteria for
the diagnosis of OIHD varied across the included studies; signs and symptoms of OIHD were assessed by dermatologists,
by study personnel, or by the part icipants.
2 Downgraded by one level due to the indirectness of the results. None of the studies reported direct ly on treatment
discont inuat ion due to adverse ef fects. Instead, the extracted results are based on dropout analyses, which did not focus on
adverse ef fects. For the remaining two studies in this comparison the dropout analyses were not detailed enough to extract
how of ten adverse ef fects were a reason. It cannot be fully excluded that some of the part icipants who completed these
studies may have stopped applying the products without the researchers’ knowledge.
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Barrier creams and moisturisers compared to no treatment for preventing occupational irritant hand dermatitis
Patient or population: workers at risk of occupat ional irritant hand dermatit is
Setting: metal factories
Intervention: barrier creams and moisturisers
Comparison: no treatment
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no treatment Risk with barrier
creams and moisturis-
ers
The proport ion of
part icipants developing
any signs and symp-
toms of OIHD (incident
cases) measured by
clinical scores (IGA) or
hand dermatit is scores
(e.g. HECSI, Manus-
core), or both, as
rated by the invest iga-
tor (physician/ nurse) or
the part icipant (propor-
t ion of OIHD)
Follow up: median 12
months
Study populat ion RR 0.68
(0.33 to 1.42)
474
(2 RCTs)
⊕⊕©©
LOW 1
126 per 1000 85 per 1000
(41 to 178)
Frequency of treatment
discont inuat ion due to
adverse ef fects
Follow up: range 2
weeks to 12 months
All dropout reasons were unrelated to the treatment: the numbers of
part icipants who dropped out of the trial ranged f rom 8% to 24%
100
(1 RCT)
⊕⊕⊕©
MODERATE2
Information only avail-
able f rom dropout anal-
yses, which were not
designed to detect ad-
verse ef fects
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*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI). The risk in the comparison group is based on mean proport ion observed in the comparison groups.
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io; OIHD: occupat ional irritant hand dermatit is
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded by two levels. Downgraded one level for imprecision because the conf idence intervals were wide and included
1 as well as a clinically signif icant relat ive risk (0.75 or less). Downgraded one level for inconsistency because criteria for
the diagnosis of OIHD varied across the included studies; signs and symptoms of OIHD were assessed by dermatologists,
or by the part icipants.
2 Downgraded by one level due to the indirectness of the results. None of the studies reported direct ly on treatment
discont inuat ion due to adverse ef fects. Instead, the extracted results are based on dropout analyses, which did not focus on
adverse ef fects. For the remaining study in this comparison no dropout analysis was performed. It cannot be fully excluded
that some of the part icipants who completed these studies may have stopped applying the products without the researchers’
knowledge.
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Skin protection education compared to no or minimal intervention for preventing occupational irritant hand dermatitis
Patient or population: workers at risk of occupat ional irritant hand dermatit is
Setting: slaughterhouses, nursing schools, and hospitals
Intervention: skin protect ion educat ion
Comparison: no or minimal intervent ion
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no or minimal
intervention
Risk with skin protec-
tion education
The proport ion of
part icipants developing
any signs and symp-
toms of OIHD (incident
cases) measured by
clinical scores (IGA) or
hand dermatit is scores
(e.g. HECSI, Manus-
core), or both, as
rated by the invest iga-
tor (physician/ nurse) or
the part icipant (propor-
t ion of OIHD)
Follow up: range 1 years
to 3 years
Study populat ion RR 0.76
(0.54 to 1.08)
13551
(3 RCTs)
⊕©©©
VERY LOW 2
275 per 1000 209 per 1000
(148 to 297)
Frequency of treatment
discont inuat ion due to
adverse ef fects
Follow up: range 2
weeks to 12 months
All dropout reasons were unrelated to the treatment: the numbers of
part icipants who dropped out of the trial ranged f rom 35% to 38%
250
(1 RCT)
⊕⊕⊕©
MODERATE3
Information only avail-
able f rom dropout anal-
yses, which were not
designed to detect ad-
verse ef fects
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*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI). The risk in the comparison group is based on mean proport ion observed in the comparison groups.
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io; OIHD: occupat ional irritant hand dermatit is
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 ’ef fect ive sample size’ af ter correct ing for cluster design in one study; number of natural part icipants: N = 1443
2 Downgraded by three levels. Downgraded one level for risk of bias as the risk rat ios may have been overest imated (due to
detect ion bias and baseline imbalance) or underest imated (due to dif ferent ial diagnost ic criteria). Downgraded one level for
imprecision because the conf idence intervals were wide and included 1 as well as a clinically signif icant relat ive risk (0.75 or
less). Downgraded one level for inconsistency because criteria for the diagnosis of OIHD varied across the included studies;
signs and symptoms of OIHD were assessed by a physician, or by the part icipants.
3 Downgraded by one level due to the indirectness of the results. None of the studies reported direct ly on treatment
discont inuat ion due to adverse ef fects. Instead, the extracted results are based on dropout analyses, which did not focus
on adverse ef fects. For the remaining two studies in this comparison no dropout reasons were reported. It cannot be fully
excluded that some of the part icipants who completed these studies may have stopped applying the products without the
researchers’ knowledge.
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D I S C U S S I O N
Summary of main results
We included nine randomised controlled trials (RCTs) involving
2888 initially randomised participants without occupational ir-
ritant hand dermatitis (OIHD) from different occupations. The
primary outcomes were signs and symptoms of OIHD developed
during the trials, and the frequency of treatment discontinuation
due to adverse effects. Six studies including 1533 participants in-
vestigated the effects of barrier creams, moisturisers, or both, com-
pared to no intervention. Three studies including 1355 partici-
pants assessed the effectiveness of skin protection education on
the prevention of OIHD compared to no intervention. Among
these four types of intervention, the comparability of the studies
was limited since the criteria for assessing signs and symptoms of
OIHD, the products, and the occupations varied.
The trials involved metal workers exposed to cutting fluids, dye
and print factory workers, gut cleaners in swine slaughterhouses,
cleaners and kitchen workers, nurse apprentices, hospital employ-
ees handling irritants, and hairdressing apprentices. All studies
were undertaken at the respective work places. Study duration
ranged from four weeks up to three years. The participants’ ages
ranged from 16 to 67 years.
We performed four meta-analyses, each comprising a maximum
of four trials, for the primary outcome of signs and symptoms
of OIHD. The meta-analyses for barrier creams, moisturisers, a
combination of both barrier creams and moisturisers, or skin pro-
tection education showed imprecise effects favouring the inter-
vention. Barrier creams alone were investigated for metal work-
ers, print and dye industry workers and may have a limited pro-
tective effect in these occupations compared to no intervention
(Analysis 1.1; low-quality evidence according to GRADE criteria).
Moisturisers alone were investigated for metal workers and may
have a clinically important protective effect in these occupations
compared to no intervention (Analysis 2.1; low-quality evidence).
Likewise, there may be a clinically important reduced risk of de-
veloping OIHD in participants using a combination of barrier
creams and moisturisers (Analysis 3.1; low-quality evidence). We
are uncertain whether skin protection education has a protective
effect in gut cleaners and nurse apprentices (Analysis 4.1; very-low
quality evidence).
Sensitivity analyses showed that the findings concerning barrier
creams were robust (Table 1), but the findings concerning the
other interventions were not, as the magnitude of the protective
effects varied depending on which trials were included (Table 4;
Table 6; Table 7).
When we excluded Brüning 2008, the meta-analyses revealed
slightly stronger preventive effects of barrier creams (Table 1), and
considerably stronger effects of moisturisers (Table 4), or both
(Table 6). In this study theremight have been some contamination
due to the partial split-body design.
Nomajor harmful or other adverse effects were identified. None of
the studies addressed the frequency of treatment discontinuation
due to adverse effects of the products directly. However, in four
studies the dropout reasons were unrelated to adverse effects. The
investigated interventions to preventOIHDprobably cause few or
no serious adverse effects. The quality of evidence was moderate,
according to GRADE criteria.
Although the findings of this review were generally positive, the
results were imprecise and the GRADE quality of evidence con-
cerning effectiveness was rated as low or very low. We concluded
that there is insufficient evidence, at present, for the effectiveness
of most of the interventions identified for preventing new cases of
OIHD in the workplace.
Overall completeness and applicability of
evidence
There are a number of potential limitations to the applicability of
the findings of this review. We identified only a limited number
of randomised controlled trials investigating the effectiveness of
measures to prevent OIHD under field study settings in different
occupations. The lack of studies may be due to the high costs and
effort involved in conducting field studies rather than ineffective-
ness of primary prevention measures. Also, such studies are not
required in order to sell barrier creams and moisturisers as they are
classed as cosmetics.
In occupational settings, chronic OIHD is caused by a summa-
tion of subclinical exposures. Two of the nine studies we identi-
fied were short-term studies (28 and 29 days) providing only lim-
ited information on long-term effectiveness.Occupational irritant
hand dermatitis is most prevalent in workers who have been ex-
posed to high cumulative irritant damage (Malten 1981). Quite a
long observation period is necessary when the effect of protective
measures in a field study setting should be evaluated (Bauer 1997;
Bauer 1998; Smit 1994; Uter 1998a). Moreover, interindividual
differences in susceptibility and regenerative capacities play a ma-
jor role, indicating an individual threshold for irritation (Agner
1991; Fartasch 1995; Pinnagoda 1989; Rietschel 1997; Tupker
1989a; Tupker 1989b; Kezic 2009).
No RCTs on the use of gloves for preventing OIHD were identi-
fied.We speculate that this is mainly because in many occupations
it would be unethical to assign participants to a control group
without glove use. In practice, guidelines and recommendations
on glove use are mainly based on rules and regulations as well as
on expert opinion (Mellström 1994).
Apart from OIHD, the review outcomes (including adverse ef-
fects) were usually addressed in very few studies, allowing only a
narrative description of the findings.
Despite the limited body of evidence, our results do provide in-
formation on the effectiveness of barrier creams and moisturisers
in primary prevention. However, there is insufficient evidence to
make recommendations about their use. The data suggest that
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protection creams, moisturisers may reduce the risk of developing
signs of OIHD to some extent. From the observed confidence in-
tervals, we consider it unlikely for any intervention to reduce the
risk to 50% or less. Policy makers, providers and users of primary
prevention strategies for OIHD may find this information useful.
Quality of the evidence
For barrier creams, moisturisers, or both, we assessed the quality
of evidence (according to GRADE criteria) as low concerning out-
come 1 (the proportion of participants developing OIHD). We
downgraded our quality assessments for these comparisons by two
levels because the results were imprecise and included inconsistent
outcomes, as described below (Summary of findings for the main
comparison; Summary of findings 2; Summary of findings 3). For
skin protection education, we assessed the quality of evidence as
very low, according to GRADE criteria (Summary of findings 4).
We downgraded our quality assessment for this comparison by
three levels because the results were imprecise, included inconsis-
tent outcomes, and were subject to a high risk of bias (the risk
ratio may have been underestimated or overestimated). Since only
few studies could be included in each comparison and the upper
limits of the confidence intervals only barely included 1 (except
for barrier creams and moisturisers combined), it is very likely
that future research will have an important impact on deciding
whether or not the investigated interventions do reduce the risk
of developing signs and symptoms of OIHD.
We assessed the quality of evidence for primary outcome 2 (safety)
as moderate for all comparisons because the only available data
were indirect.
We did not apply the GRADE criteria to the secondary review
outcomes because they are not among our key outcomes. Very few
data were reported for these outcomes and meta-analyses were not
possible.
A variety of scores were assessed and are described in the
Characteristics of included studies tables (Brüning 2008; Halkier-
Sørensen 1993; Kütting 2010; Meer 2015; Perrenoud 2001a).
They either consisted of three categories or were quantitative. In
most cases, the scores were apparently developed by the study in-
vestigators and not validated. The two exceptions were Kütting
2010, with good to excellent inter- and intra-observer reliability,
andMeer 2015, which applied a participant-reported ratingwhich
belongs to a validated questionnaire (NOSQ 2002).
TEWL or corneometry (or both) were measured in four studies
(Brüning 2008; Goh 1994; Halkier-Sørensen 1993; Perrenoud
2001a). The methods were generally well-described and adequate,
but it was not always ensured that the measurements were taken
from the exact same skin areas (Brüning 2008; Perrenoud 2001a).
Skin signs and symptoms of OIHD occur after repetitive contact
with various irritant factors (known as consecutive subclinical irri-
tation).OIHDdevelops over an extendedperiod of time (weeks up
to months). Therefore extended study periods are necessary. The
study period was adequate in the majority of studies: three years
(Löffler 2006), one year (Duca 1994; Brüning 2008; Flyvholm
2005; Kütting 2010; Meer 2015), and six months (Goh 1994).
However the study period was too short to investigate a long-term
protective effect in two studies: 28 days inHalkier-Sørensen 1993,
and 29 days in Perrenoud 2001a.
Study limitations (design and risk of bias)
In each of the three comparisons of barrier creams and/or mois-
turisers, one trial was cluster-randomised without correction
(Kütting 2010). For educational programmes two out of three tri-
als lacked appropriate correction for the design effect. We did not
downgrade our GRADE quality assessments in any of these cases
because sensitivity analyses showed that correcting for any value of
design effect would not change the conclusion that the preventive
effects were not significant.
Across all domains and trials the risk of bias was predominantly
unclear.We decided not to downgrade our GRADE quality assess-
ments for the comparisons of barrier creams and/or moisturisers.
Biases generally result in more positive effect estimates whereas the
observed effects were often small and mostly not significant in the
included trials. There was no evidence to lower our confidence in
the estimated RRs concerning risk of bias.
For skin protection education, the risk of bias was mainly unclear
but was high for some domains. The relative risk may be higher
than estimated due to lack of blinding of outcome assessors and
baseline imbalances in Flyvholm 2005. On the other hand, RR
may be lower than estimated due to an overestimation of OIHD in
the intervention group in Meer 2015.We downgraded the quality
of evidence of the primary review outcome 1 by one level for this
comparison.
Inconsistency of results
Concerning methodological consistency, the diagnostic criteria
for the diagnosis of OIHD varied across the included studies.
Signs and symptoms of OIHD were assessed by dermatologists
(Brüning 2008), by study personnel (Duca 1994; Goh 1994;
Halkier-Sørensen 1993; Löffler 2006; Perrenoud 2001a), or by the
participants (with a standardised interview, as in Kütting 2010,
or with the validated questionnaire NOSQ 2002, as in Flyvholm
2005; Meer 2015). None of the trials was designed to exclude
endogenous/atopic hand eczema or allergic contact dermatitis of
the hands. Non-occupational hand eczema could not be excluded,
either.
The limited number of eligible studies and the even smaller num-
ber of studies reporting manifest hand eczema made it necessary
to define the key review outcome very broadly and investigate any
signs and symptoms of OIHD. Accordingly, the majority of the
studies showed methodological weaknesses. A variety of non-stan-
dardised semi-quantitative methods were used to assess the key
review outcome signs and symptoms of OIHD. In two studies the
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criteria were not described; four studies reported any irritant skin
changes; and three studies had the presence of OIHD assessed by
the participant.
Therefore, we downgraded our GRADE assessments of the pri-
mary review outcome 1 by one level for all comparisons. This limi-
tation will be an issue until further studies, with more consistently
defined outcomes concerning OIHD, are available for subsequent
updates of the review.
Another methodological inconsistency concerns the study popu-
lations. Occupations varied across trials evaluating barrier creams,
and skin protection education, respectively. Moreover, the work-
ers were employed in their respective occupations for varying and
often unreported durations. While it is hard to tell whether this
introduced a bias, it does lower our confidence in the results. Still,
since we already downgraded for methodological inconsistency,
we judged that no further downgrade was necessary.
Concerning statistical consistency of the results, two studies
showed less positive or even negative effects of their respective in-
terventions, possibly due to their study designs (Brüning 2008;
Meer 2015). However, we decided not to downgrade our GRADE
ratings of these comparisons further because the inconsistencies
were not significant and 95% confidence intervals did overlap.
Also, themain problem introduced by statistical inconsistency was
the wide confidence intervals. This issue was already considered
when we downgraded by one level due to imprecision.
Indirectness of evidence
For signs and symptoms of OIHD, no comparison was down-
graded for indirectness of the evidence because the populations,
interventions, comparisons, and outcome measures were reported
as predefined for the review.
We downgraded the primary review outcome 2 by one level due to
the indirectness of the results throughout all comparisons.None of
the studies reported directly on treatment discontinuation due to
adverse effects. Instead, the extracted results are based on dropout
analyses, which did not focus on adverse effects of the interven-
tions. No study reported whether or not treatment was discon-
tinued by participants who did not drop out. For several studies,
dropout analyses were not performed or not detailed enough to
extract whether or not adverse effects were among the reasons.
Imprecision
None of the comparisons yielded significant results. However, the
confidence intervals included 1 as well as clinically relevant RRs
of 0.75 or less and were therefore too wide to be certain that the
interventions had no impact.
For all comparisons, we downgraded our quality assessments of
the evidence for primary review outcome 1 by one level due to
imprecision.
Publication bias
An assessment of the reporting bias was not possible (Assessment
of reporting biases). We did not downgrade any comparison due
to publication bias.
Potential biases in the review process
We did not impose any language restriction and searched the grey
literature, proceedings of relevant conferences, and contacted ex-
perts of the field.However, wemight havemissed trials on primary
prevention of OIHD, especially those not published because of
null or negative findings (publication bias). Therefore potential
biases in the review process cannot be excluded.
In this review, we interpreted prevention as meaning interventions
applied to healthy people. We chose to investigate the effective-
ness of primary preventive measures applied to people who were
assessed by the study investigators as not having any signs or symp-
toms ofOIHD. In reality therewill be someparticipantswith some
level of disease especially when it is very prevalent like dermatitis,
or there will be those who have not (yet) asked for medical help
because they are not aware that they have a medical problem. We
acknowledge that exclusion of studies that were not primary pre-
vention studies, i.e. where some participants had existing OIHD
(unless the participant population was mixed and disaggregated
data was available for those participants who were healthy with no
OIHD at the start of the study), may not be directly applicable to
field conditions. Interventions to prevent worsening or improve
existing OIHD are available, but analysis of their effectiveness was
outside the scope of this review and should be addressed in a sep-
arate systematic review.
Most included studies assessed the proportion of hand eczema.
However, other dichotomised data were chosen for the primary
outcome 1. Also, the time point varied across studies as we always
used data from the last follow-up. The weighting of trials in the
meta-analyses led to an over-representation of studies that focused
on minor irritant skin changes. The alternative would have been
to weight all studies equally. We discarded this option because the
primary outcome was any signs and symptoms of OIHD, and
because only five of the nine trials assessed hand eczema or hand
dermatitis. A related problem was that the confidence intervals of
the risk ratios depend on the numbers of cases. This means that
confidence intervals tended to be broader in studies which ob-
served OIHD and narrower in studies which observed any irritant
skin changes. The results of the meta-analyses must be considered
as preliminary.
Subjectivity occurred while judging the risk of performance bias
and conducting GRADE quality assessments. One could judge
that not blinding the participants introduces only a low risk of
performance bias concerning the outcome OIHD (instead of an
unclear bias). The risk of attrition bias might as well be judged as
high in some cases, butwe decided to judge the risk as unclearwhen
the dropout reasons were not distinctly connected to the outcome
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OIHD. Other researchers might have further downgraded the
quality of evidence based on the unclear risk of bias in most trials
and domains.
Agreements and disagreements with other
studies or reviews
We compared our findings to other reviews in this field of investi-
gation. Individual studies were outside the scope of this overview.
The principles and measures of technical-organisational hazard
control and individual protective measures in workplaces where
the skin is at risk arewell-defined (Halkier-Sørensen 1993;Mathias
1990; Wigger-Alberti 1997). In the available literature, barrier
creams and gloves combined with adequate moisturisers are rec-
ommended widely as the most important means of personal pro-
tective equipment in professions with skin hazards.
In their 2003 review of skin protection creams (barrier creams) for
the prevention of occupational dermatitis, Kütting and Drexler
identify most of the studies included in our review which were
available by that time (Duca 1994; Goh 1994; Perrenoud 2001a,
but not Halkier-Sørensen 1993) (Kütting 2003). Moreover, they
discuss experimental trials, primary prevention trials, and trials
which were not randomised. They argue that it is unclear whether
experimental settings are suitable to simulate real workplace con-
ditions. Most clinical trials they identify were too short, did not
have a non-intervention control, or were only suited to evaluate
therapeutic effects. Similar to our findings, they conclude that
they could not answer the question whether or not barrier creams
and gloves can prevent or provoke contact dermatitis based on
the available data. Concerning the protection of barrier creams
against resorption of dangerous substances at the workplace, they
conclude that the data was controversial. This question was be-
yond the scope of our review. Kütting and Drexler summarised
that further studies under workplace conditions were needed in
order to give evidence-based recommendations about skin protec-
tion measures.
Saary and colleagues systematically reviewed the literature on the
treatment and prevention of contact dermatitis (Saary 2005).
Their focus is on occupational dermatitis, but experiments and
studies involving other populations are included. They found
good-quality evidence that certain barrier creams can prevent ir-
ritant contact dermatitis. There is also good-quality evidence for
the preventive effects of moisturisers, especially with high lipid
content. Saary and colleagues could not identify any good-qual-
ity studies on educational programmes and found little evidence
of their preventive effects. One fair-quality study shows evidence
that the use of cotton glove liners prevents from signs of irritant
contact dermatitis that originates from wearing occlusive gloves.
Kampf and colleagues reviewed the prevention of irritant dermati-
tis among health care workers concerning hand hygiene practices
(Kampf 2007). They report that there exists category IA (CDC/
HICPAC guidelines) evidence concerning the recommendations
of hand wash with soap and hand disinfection. The review con-
cludes that healthcare workers should wash their hands with soap
and water only as a rare exception, when there is visible soiling. In-
stead, they recommend to apply alcohol-based hand rubs routinely
when the hands have been contaminated. While this question was
beyond the predefined comparisons of our review (except as part
of an educational programme), the recommendations are highly
relevant for the prevention of OIHD in health care workers.
Kütting and Drexler reviewed the efficacy of the three-step pro-
gramme of skin protection for primary prevention as opposed to
secondary prevention (Kütting 2008).While the review focuses on
occupational dermatitis, trials involving other populations are not
excluded. Kütting and Drexler encourage the avoidance or sub-
stitution of hand cleansing, but the evidence they present is very
scarce. Based on three studies, Perrenoud 2001a, Berndt 2000,
and McCormick 2000, they report no significant benefit of bar-
rier creams compared to vehicles or an oil-containing lotion. They
found very weak but undisputed evidence that barrier creams may
help in removing contaminations more gently (Mathias 1990).
Morevover, they point to adverse effects of barrier creams (in-
creased susceptibility to irritants or allergens), which are reported
in four studies. Three studies, which were excluded from our re-
view, also report an increased susceptibility after the use of skin
care creams (moisturisers). However, Kütting and Drexler argue
that skin care can be used after work without the risk of an in-
creased resorption of working substances. They report that after-
work skin care can prevent OIHD in subclinically damaged skin,
based on five trials which were not included in our review. They
also present four studies which show benefits of educational pro-
grammes (excluded from our review). Nevertheless, they conclude
that a primary prevention benefit of barrier creams and skin care
creams is not yet based on evidence.
With reference to Saary 2005, and some individual studies,
Nicholson reports mixed evidence for the protective effects of pre-
work (barrier) creams (Nicholson 2010). This paper concludes
that some creams may have protective effects, but that pre-work
creams are not generally effective in the prevention of OIHD; only
scarce information on protective gloves is presented. They found
evidence that educational programmes help to reduce the inci-
dence of occupational hand dermatitis. Only one of the three ref-
erenced studies matched our inclusion criteria (Flyvholm 2005).
Referring to Saary 2005, and the trial Arbogast 2004, Nicholson
et al report that regular application of emollients helps to prevent
occupational contact dermatitis.
One systematic review looks at RCTs and controlled clinical trials
(CCTs) on primary and secondary prevention strategies of patients
who are at risk of hand dermatitis or have signs and symptoms,
i.e. their review is not limited to occupational irritant dermati-
tis (Van Gils 2011). They include only two of the trials that are
also included in our review. Their results are hard to compare to
those of our review because the outcomes were categorised as ’oc-
currence’ of hand dermatitis, ’adherence to preventive measures’,
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’clinical outcomes and skin condition’ (including signs of hand
dermatitis), and ’self-reported outcomes’ (including self-reported
hand dermatitis). Moreover, the varying preventive strategies were
not presented separately. Van Gils et al conclude that there is evi-
dence that preventive strategies are effective for workers at risk for
or with hand dermatitis. Our meta-analyses provide only limited
support for this assessment.
In Holness 2013, the evidence on occupational dermatitis pre-
vention is briefly reviewed. She identifies systematic reviews and
summarises that their results found moderate evidence for the ef-
fectiveness of prevention programmes (Saary 2005; Bauer 2010;
Nicholson 2010; Van Gils 2011). She also argues that protective
creams, while shown to be effective in experimental studies, may
be applied in too small amounts in real workplace environments.
Based on the findings of Saary 2005, one paper reports that barrier
creams show varying effects in interventional trials (Hines 2017).
Referring to Kütting 2008, and Zhai 2006, they judge that re-
cent research does demonstrate the effectiveness of barrier creams.
Kütting and Drexler however indicate that only minimal evidence
is available for the effectiveness of barrier creams whereas Zhai et
al report that there is good evidence from experimental studies.
Hines and colleagues also point to the significant benefit reported
by Kütting 2010, referring to the outcome ’skin score’, whereas
the efficacy of barrier creams in this study is substantial but not
significant for our primary outcome. Concerning skin care creams
(moisturisers), Hines and colleagues consider four studies of pri-
mary research. Half of these studies are also included in our re-
view (Goh 1994; Kütting 2010), while the other two are excluded
because they are not primary prevention trials (Arbogast 2004;
Winker 2009). Hines and colleagues adopt the study investigators’
conclusions that skin care creams are beneficial, but they do not
report or discuss how the effectiveness is measured.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Low-quality evidence suggests thatmoisturisers alone or combined
with barrier creams may achieve a clinically important protective
effect, either in the long- or short-term, for primarily preventing
occupational hand dermatitis (OIHD).
Low-quality evidence indicates that barrier creams alone may have
a slight protective effect on OIHD, but this does not appear to
be clinically important. We are unsure whether the result for edu-
cational interventions can be generalised for practical application
because of the very low quality of the evidence.
The interventions probably cause few or no serious adverse effects.
There is a complete absence of evidence to support or refute the
use of protective gloves in the prevention of OIHD. However,
protective gloves are indispensable for personal protection against
chemical, biologic and physical hazards in many occupations.
We conclude that at present there is insufficient evidence to confi-
dently assess the effectiveness of interventions used in the primary
prevention of OIHD in the workplace. This does not necessarily
mean that current measures are ineffective. There is still a need
for trials which apply standardised measures for the detection of
OIHD in order to determine the effectiveness of the different pre-
vention strategies.
Implications for research
The absence of substantial evidence of efficacy to support specific
or complex interventions that are in use for the primary preven-
tion of OIHD does not necessarily imply that they are not effec-
tive. Our results indicate that further large randomised controlled
trials (RCTs) over extended time periods (six months up to one
year) are needed to determine whether complex or single interven-
tions for preventing OIHD in skin risk occupations are working.
There is not enough evidence available at present to comment on
whether moisturisers, barrier creams, gloves, and other skin pro-
tection measures work in real-world wet work settings. Further
trials, which are pragmatic (in real-life conditions, to determine
if an intervention works or not) and explanatory (in experimen-
tal conditions, to determine why and how an intervention might
work), could explore the effectiveness of gloves, barrier creams,
and moisturisers in different occupational settings with different
irritant profiles. Such studies need to include new cases and exam-
ine primary prevention strategies in different work places.
In particular, we noticed a lack of RCTs concerning the effective-
ness of gloves. While it may often be unethical to prohibit control
group participants from using gloves, future studies can evaluate
the effectiveness of different gloves, the use of cotton liners, or
compare the promoted use of gloves to usual practice.
The agreement on diagnostic criteria of established OIHD are
quite clear, but research should be directed to further develop and
validate hand dermatitis scoring systems for a better and standard-
ised discrimination of irritant skin changes from irritant contact
dermatitis. A standard core outcome set is necessary in order to
allow more direct comparisons across studies.
Researchers conducting cluster-randomised trials need to apply
a correction for the design effect to their evaluations as well as
to their sample size calculations. Published intraclass correlation
coefficients (ICCs) are lacking in the context of OIHD. Reporting
ICCs would not only improve an individual study’s quality, but
also provide comparable estimates for planning and evaluating
other studies. Even publishing ICCs for trials which are already
concluded will be a valuable contribution. Currently, the only
available ICC estimate in this context is low (Meer 2015; ICC =
0.005) but may be considerably higher in other studies. Sample
sizes for future trials must be inflated accordingly.
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Future researchers should be aware that having OIHD assessed
by the participants has its strengths and weaknesses. On the one
hand, it may be more convenient and it makes it possible to detect
OIHD not only at a specific time point, but over a larger range
(e.g. three or sixmonths), which producesmore cases and therefore
yields higher power. On the other hand, participants are harder to
blind in comparison to study personnel. Also, participants of the
intervention groups may be more sensitised to spotting OIHD
compared to the controls.
In order to facilitate subgroup analyses, researchers should addi-
tionally present their data stratified by sex, age (more or less than
30 years), history of atopy and hand dermatitis.
Various in vivo and in vitro methods are in place to investigate
the efficacy of skin protective measures under experimental con-
ditions (Boman 1989; Frosch 1994; Gabard 1995; Henry 1994;
Mellström 1994; Treffel 1994; Wahlberg 1996; Zimmerli 1996).
The results of those experimental studies are not sufficient to fore-
cast the effectiveness of the products under real-life conditions.
In skin risk occupations, the controlled conditions of an experi-
mental setting never exist and a variety of irritants and allergens as
well as mechanical factors may repetitively impair the skin at the
same time or follow each other. Field studies therefore seem to be
the best way to ensure that recommendations given are substan-
tiated by evidence. However, field studies incur specific problems
like the possible contamination of the groups after randomisation,
difficulties with blinding, the necessity of large sample sizes, and
changes in compliance because of the presence of the investigator
(Coenraads 2003).
In addition, it is challenging to conduct RCTs in the workplace en-
vironment. While high-quality evidence is still lacking, it may be
helpful to conduct another systematic review with broader inclu-
sion criteria (e.g. experimental trials, non-randomised controlled
trials) in order to provide a complete overview of the available ev-
idence. However, data from experimental settings is hardly mean-
ingful to forecast efficacy at workplaces, and the inclusion of con-
trolled clinical trials would lead to an even lower evidence level.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Brüning 2008
Methods Individually randomised controlled trial
Combination of parallel and split-body design, 2x2 arms
Duration: 12 months
3 follow-ups at 3, 6, and 12 months
Participants Final number evaluable after 12 months: N = 96 healthy metal workers exposed to
cutting fluids
• Group 1 (N = 46): skin protection/no product on randomly allocated hand
• Group 2 (N = 50): skin protection + skin care/skin care only on randomly
allocated hand
Number of participants randomised: N = 100 (group 1: N = 50; group 2: N = 50)
Lost to follow-up: 4 in group 1
Mean age in years (participants evaluable after 12 months): group 1: 35.5 (range 17
to 59); group 2: 41.5 (range 17 to 59)
Sex: male
Inclusion criteria
• Male
• 17-65 years
• Exposure to cutting fluids
• Forced to mostly work without hand gloves
• Written consent
Exclusion criteria
• Female
• Fitzpatrick skin type IV, V , VI
• Hand eczema during recruitment
• Local therapy of the hands
• Intake of cortisone or immunosuppressives 3 weeks before recruitment
• Absence from factory for 3 months or more
Setting: one medium-sized German factory
Interventions Comparison of the effectiveness of skin protection, skin care, or both, versus no inter-
vention (4 study arms, all relevant to the review). The metal workers’ hands were ran-
domised to:
• Travabon or Stoko Protect (skin protection / barrier cream);
• Estolan (skin care/moisturiser);
• both;
• no intervention.
No details on application described, but participants received a flyer and the product.
One-sided application using a glove for the other hand. Participants were randomised
to use product on either left or right hand
Outcomes 1. Proportion of OIHD: after 12 months, abnormal morphology (’klinischer
Hautbefund’) was assessed by study physician. Conspicuous and minor conspicuous
findings were extracted as signs and symptoms of OIHD.
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2. Treatment discontinuation due to adverse effects: all 4 withdrawals were due to
personal reasons. We deduce that there were no cases of treatment discontinuation due
to adverse effects.
3. TEWL and skin hydration were extracted (only quartiles, no mean or SD given)
4. Microtopographic parameters (not extracted for this review)
All outcomes were measured at baseline, after 3, 6, and 12 months. For the visits at 3
and 6 months, abnormal morphology was not reported while the other outcomes were
reported in diagrams of the medians only
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD)
Strengths
• Clinical examination by dermatologists was performed. Good method to assess
prevalence of hand eczema.
Limitations
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• Broad outcome definition -> comparatively many cases expected;
• Time frame: point prevalence
Scoring system for the severity of OIHD: the study investigators applied a score which
consisted of 3 categories: ’unauffällige klinische Befundung’ (inconspicuous findings),
’geringfügig auffällige klinische Befundung’ (minor conspicuous findings) and ’auffällige
klinische Befundung’ (conspicuous findings).
Strengths
• Blinded: the dermatologist did not know which group the participant belonged to
• Double assessment: a second dermatologist independently assessed a photograph
of the skin
• Already minor symptoms were noted
Limitations
• Score not validated for inter- or intra-observer reliability
• Not based on different symptoms or extent of affected area (objective parameters)
• Very subjective
Quality of bioengineering methods (Pinnagoda 1990): the measurements were per-
formed on four defined skin areas (back of the left and right hand, distal part of the volar
site of the lower left and right arm) after a 20-minute adjustment phase at a standardised
temperature (20°C) and relative humidity (50%). The participants were asked not to
take a shower, eat or drink anything and to refrain from smoking within the hour before
the measurement. TEWL was measured according to international recommendations
(Pinnagoda 1990, Rogiers 2001). For the corneometry, electrical measurements of con-
ductibility (κ), impedance ( ) and capacity (F) were performed
Strengths
• Information on the test room is given (temperatures, relative humidity)
• Measurements were taken in a standardized environment (temperature, relative
humidity)
• Potentially interfering factors were excluded (shower, food, drinks, smoking)
• An adjustment phase of 20 minutes was allowed before measurements
• Method is well-described
Limitations
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• No information is given on the instruments
• Measurements were taken on the back of the hand and the distal part of the volar
site of the lower arm. Rather vague information. Does not ensure that measurements
were performed always in the exact same area.
Notes The left/right hand design may have led to failures when applying the products
Study funding sources: Vereinigung der Metall-Berufsgenossenschaften (VMBG) (fi-
nancial, content-related and organisational support)
Possible conflicts of interest not described.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not described. Quote: ’Während
der Erstuntersuchung wurden die Proban-
den zufällig in zwei Gruppen aufgeteilt.
Danach erfolgte in jeder Probandengruppe
die zufällige Aufteilung der Probanden
in jeweils zwei Interventionsarme (jew-
eils einer pro Hand).’ (p. 7) [At base-
line, probands were randomly assigned to
two groups. Subsequently in each group of
probands, the probands were randomly as-
signed to two intervention arms each (one
for each hand).]
Allocation concealment (selection bias) Unclear risk Block randomisation was performed, no
details given. Unclear selection bias
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding of participants, participants
could have influenced performance by in-
tentionally applying products to the wrong
hand. Possible influence on proportion of
OIHD
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Physician was blinded.
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Low risk No influence of blinding is expected for
these objective measurements
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Low risk Only 4 withdrawals, due to personal rea-
sons, in group 1 (control/skin protection)
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
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Selective reporting (reporting bias) Unclear risk No protocol available. All outcomes men-
tioned in the report were reported at least
for first and last examination
Other bias Unclear risk Design: more than one intervention arm.
This was accounted for in meta-analysis.
The control group was not double-counted
within one meta-analysis
The split-body designmay have introduced
contamination, especially concerning the
control arm. (unclear risk)
Baseline imbalances
• Median age 35.5 in group 1 (skin
protection, control) vs 41.5 in group 2
(skin protection + care, skin care)
• 2.2% left-handed in group 1 vs 10%
in group 2
• Slightly more smokers in group 2
• 13% with known HE in group 1 vs
24% in group 2
Blocked randomisation in unblinded tri-
als: block randomisation was performed,
no details given. Unclear selection bias
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms.
Duca 1994
Methods Individually randomised controlled trial
Parallel groups, 2 arms
Duration: 1 year
3 follow-ups at 4, 8, and 12 months
Participants Final number evaluable after 12 months: N = 497 initially healthy dye and print
factory workers (intervention: N = 248; control: N = 249)
Number of participants randomised: N = 868 (intervention: N = 428; control: N =
440)
Lost to follow-up:N = 211 (intervention: N = 102; control: N = 109)
Excluded from review due to OIHD at beginning of study: N = 160 (intervention:
N = 78; control: N = 82)
Mean age in years (all included participants): intervention: 32.6; control group: 32.1
Sex: 91% male, balanced between groups
Meanduration of employment (all 868 participants): barrier creamand control group,
7.9 years
Inclusion criteria: dye and print industry workers
Exclusion criteria: other dermatological disease on the hands
Setting: field study in 13 dye and print factories, North Italy
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Interventions Comparison of the effectiveness of:
• barrier creams 2 x/day (silicone or hydrocarbon containing formulations) versus;
• no intervention.
The workers were randomised to receive either the barrier creams (silicone or hydrocar-
bon containing barrier creams), which they used twice a day for 1 year, or no intervention
Outcomes 1. Proportion of OIHD: positive objective exam for at least one follow-up. Presence
of the following skin changes: erythema, edema, exudation, vesicles, blisters,
desquamation, hyperkeratosis, rhagades, dryness, atrophy, lichenisation. (’Positività
all’esame obiettivo in almeno un controlo.’ p. 235; ’In particolare l’esame obiettivo
consisteva nel rilevare la presenza di lesioni dermatologiche a mani e avambracci
distinguendo: eritema, edema, essudazione, vescicole, bolle, desquamazione,
ipercheratosi, ragadi, secchezza, atrofia, lichenificazione.’ p. 233)
Assessments took place after 4, 8, and 12 months.
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD):
objective skin lesions assessed by study personnel (erythema, edema, exudation, vesicles,
blisters, desquamation, hyperkeratosis, rhagades, dryness, atrophy, lichenisation)
Strengths
• Clinical examination by physicians who were trained by a dermatologist was
performed. Good method to assess prevalence of hand eczema.
Limitations
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Broad outcome definition -> comparatively many cases expected
Time frame: combined incidence at 4, 8, or 12 months
Scoring system for the severity of OIHD: no score assessed
Quality of bioengineering methods (Pinnagoda 1990): not relevant
Notes Study funding sources: Not described.
Possible conflicts of interest: Not described.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ’La procedura di randomizzazione.
....base di una sequenza di numeri casuali’
(p. 233) [The randomisation procedure ...
based on a sequence of random numbers]
Matched pairs were used in order to achieve
balanced groups.
Allocation concealment (selection bias) Unclear risk Inadequate concealment of the allocation
sequence may have resulted from pairwise
assigning the first person of the pair to
group A if the random number was even,
to group B if odd. The second person of the
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pair was assigned to the alternative group.
Efforts to conceal the allocation were not
described
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants remains unclear.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Quote: ’Controllo clinici periodici ....
all‘oscuro del gruppo’ [Periodical clinical
examination ... blinded to group] - Out-
come assessors were blinded
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Low risk TEWL and corneometry were not mea-
sured.
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Unclear risk 12 months follow-up: 102 missing from
the barrier cream group, 109 missing from
the control group due to dropout and un-
availability at the examination time points.
The study investigators did mention ITT
analysis but this merelymeant that compli-
ance was ignored. Missing values were not
estimated
Dropout was due to the long duration of
recruitment and due to workers leaving the
factories, but there was no detailed analysis
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk Insufficient information.
Other bias Low risk Design: no sources of bias were identified.
Baseline imbalances: demographic data of
participants were only available for the en-
tire study population (N = 868). It re-
mains unclear whether the demographic
characteristics of the initially healthy work-
ers from intervention and control group (N
= 708) differed significantly in this study
(low risk)
Blocked randomisation in unblinded tri-
als: not enough information was given to
decide whether or not allocation conceal-
mentwas brokenby the pairwise allocation.
(unclear allocation concealment bias)
Differential diagnostic activity:no differ-
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ent diagnostic activities across study arms.
Flyvholm 2005
Methods Cluster-randomised controlled trial; 18 clusters (departments)
Parallel design, 2 arms
Duration: 1 year
1 follow-up at 1 year
Participants Final number evaluable after 12 months:N= 212 initially healthyDanish gut cleaners
(intervention: N = 59; control: N = 153)
Number of participants randomised: N = 644 baseline responders (intervention: N =
205; control: N = 439)
Lost to follow-up: N = 228 were lost to follow-up or stopped working as gut cleaners
(intervention: N = 69; control: N = 159)
Excluded from review due to OIHD at beginning of study: N = 204 (intervention:
N = 77; control: N = 127)
Mean age in years (all follow-up respondents including those withOIHD at baseline
and those not available at baseline): intervention: 36.1 (range 17-62 years); control:
37.8 (range 17-66)
Sex: 66.3% male (intervention), 64.1% male (control)
Inclusion criteria: not described
Exclusion criteria: not described
Setting: field study in 18 swine slaughterhouses in differentDanish cities, all departments
belonging to one company
Interventions Comparison of the effectiveness of a:
• prevention programme, versus
• comparison group (probably no intervention).
The prevention strategy consisted of a two part concept, with an evidence based preven-
tion programme giving recommendations for prevention of work related skin problems
in wet work occupations, and a documented method for implementation. The recom-
mendations were aimed at the management and at the employees
• Avoid or reduce wet and dirty manual working procedures.
• Use protective gloves for wet and dirty working procedures, if possible.
• Protective gloves must be intact, clean, and dry inside and must be worn on clean,
dry, and well cared for skin.
• Use fabric gloves, e.g. cotton gloves underneath the protective gloves.
• Use a skin care product when needed during the working day and always after
work.
• Use a skin care product before wet and dirty working procedures if you do not use
protective gloves.
• The skin care product should have a high content of petrolatum and a low
content of water.
• Do not wear finger rings, jewellery, or wristwatch on hands or forearms during
work.
• Wash your hands in cool water, rinse off the soap thoroughly, and dry your hands
carefully with a soft material afterwards.
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• When there is no visible contamination of the hands, hand washing can with
advantage be substituted by an alcohol based hand disinfectant.
• Protective gloves, hand soaps, skin care products, and hand disinfectants should
be without known irritant and allergic substances or with lowest possible content of
them (p. 643).
The local project group included 2-5 gut cleaners who acted as role models
Outcomes 1. Proportion of OIHD (hand eczema): The case definition for eczema was: eczema
on hands or forearms within the past three months based on questions D1, D2, and
D5 of NOSQ 2002 (telephone interview). Assessed at 12 months.
2. Use of gloves, use of cotton gloves underneath plastic/rubber gloves, and use of
skin care products were not extracted for this review.
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD)
Strengths
• The questions used to assess the prevalence of hand eczema belong to a validated
questionnaire (NOSQ 2002).
Limitations
• Self-reporting of hand eczema underestimates the true prevalence of hand eczema.
Especially mild changes are often not reported.
• No differentiation between hand eczema and eczema on the forearms
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• relatively narrow outcome definition
• time frame: period prevalence: last 3 months -> comparatively many cases
expected
Scoring system for the severity of OIHD: no score assessed
Quality of bioengineering methods (Pinnagoda 1990): not relevant
Notes 79 participants had stopped working as gut cleaners andwere analysed as a separate group
in the report regardless of the intervention. For this review, they were not considered and
treated as dropouts. Demographic data were only available for participants who were not
lost to follow-up, including those with OIHD at baseline
There was a mistake in the paper concerning primary outcome 1, which MA Flyvholm
corrected in an email (05/052015): ’For the intervention group (corrected: comparison
group), 67% of those with eczema at baseline reported eczema at follow up and 33% no
eczema; 37% with no eczema at baseline reported eczema at follow up.’ (p. 646)
Study funding sources: ’The project was financially supported by an appropriation for
prevention of asthma and allergy, administered by the Danish Ministry of Health.’ (p.
648)
Possible conflicts of interest: none declared.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not described (’randomly allo-
cated’ p. 643).
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Allocation concealment (selection bias) Unclear risk Method not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding, possible influence on propor-
tion of OIHD.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk No blinding likely to influence reporting of
OIHD.
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Unclear risk TEWL and corneometry were not mea-
sured.
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Unclear risk 149 participants (23,1%) lost to follow-up,
an unspecified number of which (max. 51)
dropped out without stating reasons
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk Insufficient information.
Other bias High risk Design: no correction for cluster randomi-
sation -> no bias, but over-precise results
and limited comparability
Baseline imbalances
• Significantly less OIHD (eczema on
hands/forearms in the previous 3 months)
in comparison group, study investigators
explain this with the more frequent use of
gloves in one comparison department ->
high risk
• Those who stopped as gut cleaners
had worked as such for a shorter time ->
probably no bias
Blocked randomisation in unblinded tri-
als: no block randomisation reported.
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms.
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Methods Individually randomised controlled trial
Parallel groups, 3 arms
Duration: 6 months (also reported as 30 weeks) for each participant, 3 years altogether
3-weekly follow-ups
Participants Final number evaluable after 6 months: N = 54 initially healthy, newly employed
metal workers exposed to cutting fluids (barrier cream: N = 17; moisturiser: N = 14;
control: N = 23)
Number of participants randomised: N = 54
Lost to follow-up:N = 0
Mean age in years: barrier cream group: 22 (range 16 to 37); moisturiser group: 22
(range 16 to 36); control: 22 (range 17 to 35)
Sex: 50 out of 54 male
Exclusion criteria: ’Onlymachinists who had not handled cutting fluids previously were
included in the study. Machinists who had already worked for more than I week were
excluded.’ (p. 177)
Setting: field study in the grinding and turning sections of one large ball-bearing man-
ufacturing factory, Singapore
Interventions Comparison of the effectiveness of:
• a barrier cream Arretil (Stockhausen, Germany); 3 to 4 x /day, and
• an after work moisturiser Keri Lotion (Westwood Pharmaceuticals, USA); 1 x
after work, versus
• no intervention.
The participants were randomised to receive either a barrier cream (60 g tube every 6
weeks used on the hands before work and after each meal break), or a moisturiser used
daily as an after work emollient, or no intervention. Arretil is a water-soluble, non-oily,
silicone-free barrier cream. Keri lotion is a liquid paraffin lotion (16%) and contains
lanolin oil. The participants were followed up every 3 weeks for 6 months
Outcomes 1. Proportion of OIHD (as defined by the study investigators): ’All cases of cutting
fluid dermatitis were diagnosed clinically as irritant contact dermatitis’ (p. 178).
Dermatitis was assessed ’arbitrarily’ (p. 177) and ’cutting fluid dermatitis was
diagnosed on the history and clinical findings’ (p. 177) (which probably meant the
arbitrary assessment of dermatitis). The study investigators probably counted a subject
as a case when irritant contact dermatitis was diagnosed at any of the 3-weekly follow-
ups (combined point prevalence): ’Machinists who developed cutting fluid dermatitis
(cases) and those who did not (non-cases)’ (p. 178). This was measured from week 1 to
12 and subsequent 18 weeks and extracted only for the last 18 weeks.
2. The secondary outcome measures was the amount of skin barrier impairment
(TEWL) in the groups (mean and SD).
3. Frequency of treatment discontinuation due to adverse effects: No dropouts
reported.
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD):
classification of dermatitis severity: mild = less than 25% of the total surface area of either
hand involved (up to wrist line), moderate = more than 25% of the total surface area of
either hand involved (up to wrist line)
Strengths
• Clinical examination was performed. Good method to assess prevalence of hand
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eczema.
Limitations
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• Relatively narrow outcome definition
• Time frame: probably combined incidence at any weekly follow-up ->
comparatively many cases expected
Scoring system for the severity of OIHD: no score assessed
Quality of bioengineering methods (Pinnagoda 1990): ’Baseline TEWLmeasurement
was made on the skin overlying the dorsal 3rd metarcarpophalangeal (MCP) joint of
both hands with an Evaporimeter (Servomed, Vallingby, Sweden). We chose the 3rd
MCP joint because of the ease of identifying the exact spot for repeat measurements. We
conducted a pilot measurement on mid-dorsal hand, 1st, 3rd, 5th dorsal MCP joints,
mid-ventral forearms andmid-dorsal forearms on the 1st 30 volunteers. All showed fairly
consistent recordings. We found the 3rd dorsal MCP joints to have the highest TEWL
recordings and that these were fairly consistently reproducible. The method of TEWL
measurement was as follows. The machinist rested in the examination room for 10 to
15 min. The TEWL on the dorsal 3rd MCP joint of each hand was then measured.
TEWL values on the left hand followed by those on the right hand were recorded. The
procedure was repeated once. 2 recordings of TEWL values for each hand were thus
obtained; the average was recorded.’ (p. 177)
Strengths
• Information is given on instrument (Evaporimeter, Servomed, Vallingby, Sweden)
and the test room (temperatures, humidity)
• TEWL measurements were taken in a standardized environment (draft-free, air-
conditioned)
• Measurements were always taken from the same skin area
• Method is well-described
Notes Groups were comparable at baseline.
No dropouts
Study funding sources not described. (’A research grant was obtained.’ p. 176)
Possible conflicts of interest not described.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ’Machinists were randomly as-
signed.’ (p. 177). No further information
provided
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were not blinded to the in-
tervention because original samples of the
products were supplied. Possible influence
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on proportion of OIHD
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk No information provided on blinding of
outcome assessors.
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Low risk No influence of blinding is expected for
the objective measurement of TEWL. Cor-
neometry was not measured
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Low risk No dropouts reported in either group.
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk All outcomes reported. No protocol avail-
able.
Other bias Unclear risk Design: participants were recruited con-
secutively (when they started work) over
a period of 3 years, in which the work
conditions and exposures might have been
changed -> unclear bias
More than one intervention group. This
was accounted for in meta-analysis. The
control group was not double-counted
within one meta-analysis
Baseline imbalances: baseline imbalance
regarding turning vs grinding section: con-
trols - 14 vs 9; barrier cream - 8 vs 9; emol-
lient cream - 4 vs 10 -> unclear bias
Blocked randomisation in unblinded tri-
als: no block randomisation reported
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms
Halkier-Sørensen 1993
Methods Individually randomised controlled trial
Cross-over design, 2 arms
Duration: 2x2 weeks
2 follow-ups (at 2 and 4 weeks or at time of dropout)
Participants Final number completing the 2x2 weeks: N = 70 initially healthy cleaners and kitchen
workers
Number of participants randomised: N = 111 (N = 56 started with moisturiser; N =
55 started with no treatment)
Lost to follow-up:N = 41
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Mean age in years (groups I, II, III): 41 (range 19 to 67)
Mean duration of employment (groups I, II, III): 10 (range 1 to 35) years
Sex: 110 out of 111 included participants were female.
Setting: field study, Denmark
Interventions Comparison of the effectiveness of:
• a moisturiser Locobase (Ferndale Laboratories, USA);
• versus no treatment
in a 2x2weeks cross-over design. Application requirements were not described. Locobase,
manufactured by Ferndale Laboratories, USA, is a wound and skin emulsion formulation
intended for topical application. No details were given about the composition of the
cream
Outcomes The study investigators reported the results after grouping all participants in 4 groups
according to their ability to complete the 4 week study. Finally, only results of groups I
and II were reported
Comparisons of intervention vs no treatment were only reported for corneometry,
TEWL, and sum score in groups I and II
• Group I, N = 70, completed both periods Locobase (L) and Control (C).
• Group II, N = 23, completed L, but dropped out of in period C after developing
severe dryness of the skin.
• Group III, N = 12, violated the protocol or declined to continue the study
because they developed or feared to develop hand dermatitis during period C.
• Group IV, N = 6, turned up only once, did not find Locobase acceptable or went
on vacation.
1. Proportion of skin changes (dryness only, dryness and scaling) and OIHD (dry
eczema)
2. Biometric methods: corneometry values, TEWL (only figures and P values)
3. Subjective opinion
4. Mild adverse effects
5. A sum score was assessed, but not reported separately for incident cases of OIHD.
This outcome does therefore not fit the review’s outcomes (not extracted).
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD): the
degree of certainty could not be assessed because no diagnostic criteria for OIHD were
described
Scoring system for the severity of OIHD
• Clinical signs and symptoms assessed: Itching, dryness, scaling, fissuring,
erythema, vesiculation
• Localisation of eczema assessed: fingers, hands, wrists, arms
• Severity rating: 1 = mild, 2 = moderate, 3 = severe
• Sum Score: multiplication of the severity ratings of all symptoms and sites
(highest possible score: 8 (sites) x 7 (symptoms) x 3 (rating for severity) = 168
Strengths
• Contains different symptoms and severity rankings
Limitations
• Score not validated for inter- or intra-observer reliability
• Contains a parameter (itching) which is self-reported by the participant
• Extent of affected area is not assessed for each site
Quality of bioengineering methods (Pinnagoda 1990): ’Skin surface temperature (dig-
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ital thermometer, Ellab type TRD, probe diameter 12 mm), transepidermal water loss
(TEWL) (Evaporimeter EPI, Stockholm, Servomed, Sweden), and electrical capacitance
(Corneometer CM420, Schwarzhaupt, W. Germany) were measured on both the right
and left side and on the volar and dorsal aspect of the distal part of the 3rd finger, middle
of the hands, and on the forearms (12 measurement points). The results are presented as
overall mean values (the mean values for all measurements on all sites). All probes were
hand-held. The measurements were performed in a separate room with minor draught
and protection shields. The mean room temperature was 23°C (20-26°C) and the mean
relative humidity (RH) 34% (25-42%).’ (p. 267)
Strengths
• Information is given on instruments and the test room (temperatures, humidity)
• Measurements were taken in a standardized environment (minor draught and
protection shields)
• Measurements were always taken from the same skin areas
• Method is well-described
Notes The study investigators did not report the results according to the groups randomised,
but regrouped all participants in 4 groups according their ability to complete the 4 week
study period
Therefore not included in meta-analysis.
Study funding sources: ’The study was supported by the Danish Insurance Association,
Copenhagen, L. P. Hansen’s fund,
Odense, and Danfoss A/S, Nordborg, Denmark.’ (p. 270)
Possible conflicts of interest not described.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ’They were randomised into 2
groups’ (p. 267). No further information
provided
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were not blinded due to study
design.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Blinding of outcome assessors was proba-
bly not done. Quote: ’Clinical examination
and skin physiological measurements were
performed on entry...’ (p. 267)
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Unclear risk No influence of blinding is expected for
these objective measurements
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Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
High risk N = 23 dropped out in period C after de-
veloping severe dryness of the skin, N = 12
violated the protocol or declined to con-
tinue the study because they developed or
feared to develop hand dermatitis, N = 6
turned up only once, did not find Locobase
acceptable, or went on vacation
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk Dropout analysis did not address this out-
come conclusively.
Selective reporting (reporting bias) High risk Results were not reported according to the
original randomisation, but according to
the ability of the participants to complete
the study period. This was an attempt to
deal with the high risk of attrition bias
Consequently, the results were not reported
in a way appropriate for an RCT
Other bias High risk In-study use of moisturiser was twice as
high inparticipantswhodroppedout in the
no-treatment period (N = 23) compared to
the participants who completed both parts
of the study (2.3 g/person/day versus 1.2
g/person/day)
Design: cross-over -> unclear bias
Baseline imbalances: pre-study use of
moisturiser differed significantly between
the groups despite randomisation (96%
versus 82%, P < 0.01). -> high risk
Blocked randomisation in unblinded tri-
als: no block randomisation reported.
Differential diagnostic activity: not ap-
plicable because study arms were not eval-
uated separately
Kütting 2010
Methods Cluster-randomised controlled trial; 18 clusters (enterprises)
Parallel design, 4 arms
Duration: 12 months
2 follow-ups at 6 and 12 months
Participants Final number evaluable after 12 months: N = 800 initially healthy metal workers
exposed to cutting fluids (group 1: N = 217 in 6 enterprises; group 2: N = 209 in 5
enterprises; group 3: N = 213 in 4 enterprises; control: N = 161 in 3 enterprises)
Number of participants randomised: N = 1020 (group 1: N = 263; group 2: N = 253;
group 3: N = 258; control: N = 246)
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Lost to follow-up:N = 220 (21.6%) withdrawal/exclusion at 2nd follow-up (group 1:
N = 46; group 2: N = 44; group 3: N = 45; control: N = 85)
Median age (all included participants): group 1: 40; group 2: 40; group 3: 44,5;
control: 42
Sex: male
Inclusion criteria
• Male
• Age >= 18 y
• Regular exposure to cutting fluids
• Working contract for one further year at minimum
• Fitness for work at randomisation
• Willingness to comply
Exclusion criteria:
• Manifest hand eczema
• Intake of immunosuppressive drugs or topical application of corticosteroids or of
other immunosuppressive agents on the hands
Setting: German factories mainly of small or medium-size
Interventions Comparison of the effectiveness of skin protection and/or skin care creams vs no recom-
mendation in a 4-armed trial
• Group 1: ’skin protection programme as generally recommended (i.e. use of skin
protection and skin care)’ (p. 363). Timing not explicitly stated, but obviously skin
protection (barrier cream) before or during work and skin care (moisturiser) after work.
• Group 2: ’use of skin protection creams before or during working hours but
complete avoidance of postexposure skin care’ (p. 363)
• Group 3: ’use of skin care products solely after work’ (p. 363)
• Group 4: ’The control group did not receive any recommendations concerning
the use of skin protection or skin care.’ (p. 363) (Only 31.4% used neither skin
protection nor skin care after 6 months, 25.5% after 12 months. However, the
participants were not instructed to avoid these measures.)
Pragmatic approach: ’All participants used the skin care andprotection products provided
by the employer.’ (p. 363)
Outcomes 1. Proportion of OIHD: Dermatological history (hand eczema) in the last 6 months
as reported by the participant in a standardised personal interview. This was also
reported for the first 6 months, but not extracted for this review.
2. Severity was rated in a skin score, but not reported separately for incident cases of
OIHD. This outcome does therefore not fit the review’s outcomes (not extracted).
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD)
Strengths
• Standardised interview
Limitations
• Self-reporting of hand eczema underestimates the true prevalence of hand eczema.
Especially mild changes are often not reported.
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• Relatively narrow outcome definition
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• Time frame: period prevalence: last 6 months -> comparatively many cases
expected
Scoring system for the severity of OIHD: percentage change of skin score as primary
outcome and relative change from baseline as secondary outcome: ’A quantitative skin
score was used. In brief, the score comprised all morphological criteria and physiological
abnormalities (e.g. dryness) characteristic of hand eczema. Extent, intensity and anatom-
ical site of each type of skin lesion were also recorded.’ (pp. 363-4)
’All three physicians underwent standardized training before using the score. Moreover,
during the study period digital photographs of the hands of randomly chosen participants
were regularly evaluated and results discussed in order to maintain similarity of visual
assessments between observers.’ (p. 366)
Strengths
• Dermatologist were trained in using the score before start of study
• Good to excellent inter- and intra-observer reliability
• Quantification of minimal skin lesions
Quality of bioengineering methods (Pinnagoda 1990): not relevant
Notes Primary intervention: no inclusion of workers with manifest hand eczema (despite high
baseline values on their very sensitive score). This was confirmed through correspondence
with H Drexler
Study funding sources: ’The study was funded by the German Statutory Accident
Insurance (DGUV) and the Franz-Koelsch-Stiftung e.V.’ (p. 369)
Possible conflicts of interest: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ’Randomization was performed on
the basis of the 19 included enterprises, as-
signing each enterprise randomly to one of
four study arms.’ (p. 363)
Apparently, an undescribed method was
applied to ensure approximately equal size
of the groups despite varying numbers of
workers per enterprise
Allocation concealment (selection bias) Unclear risk It cannot be excluded that allocationwas bi-
ased by the results of the baseline screening.
Potential confounders differed significantly
at baseline. Even though the study investi-
gators do not report significant associations
with their outcomes, they did not test the
association with review outcome ’propor-
tion ofOIHD’. Baseline skin conditionwas
better in the control group, thus allowing
less improvement after 1 year compared to
other groups
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No blinding reported; possible to influence
proportion of OIHD
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Blinding of participants (= outcome asses-
sors) was probably not done. This would be
likely to influence reporting of OIHD, but
clear information on blinding is lacking
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Unclear risk No influence of blinding is expected for
these objective measurements
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Unclear risk 78.4% of recruited participants were avail-
able at last follow-up (1 year), no analysis
of dropouts
Attrition in control was 2x as high as in
other groups. ’High risk’ judgement was
therefore considered but discarded because
dropout reasons are unknown
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk Skin score was presented in various ways:
percentage change of skin score as primary
outcome, categorized percentage change as
secondary outcome; further outcomes in-
cluding absolute change of skin score were
reported. This is questionable, but at least
the study investigators did not omit their
less significant calculations
No protocol available
Other bias High risk Design: no correction for cluster randomi-
sation -> no bias, but over-precise results
and limited comparability
More than one intervention group. This
was accounted for in meta-analysis. The
control group was not double-counted
within one meta-analysis
Baseline imbalances: significant dif-
ferences of potential confounders and
dyshidrotic eczema, but not of other der-
matological disorders. It remains unclear
whether this was due to lack of allocation
concealment or happened by chance and
was worsened by the cluster design -> high
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risk of bias
Blocked randomisation in unblinded tri-
als: no block randomisation reported.
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms.
Löffler 2006
Methods Cluster-randomised controlled trial; 14 clusters (nursing schools)
Parallel groups, 2 arms
Duration: 3 years
2 follow-ups at 1.5 and 3 years
Participants Final number evaluable after 3 years: N = 250 initially healthy 1st-year nurse appren-
tices (intervention: N = 121; control N = 129)
Number of participants randomised: N = 521 (numbers of participants allocated to
groups were not reported)
Lost to follow-up:N = 196 (37.6%; dropout per group was not reported)
Excluded from reviewdue toOIHDat beginning of study: only the number of healthy
participants who were evaluable were provided (N = 250). This included participants
who had OIHD at least at 1 follow-up before they dropped out
Mean age in years (all included participants): intervention: 20.9 (SD 4.9); control:
23.6 (SD 7.7)
Sex: 13% male (intervention), 12% male (control)
Mean duration of employment: 0 years, baseline examination was before beginning of
the nurse training
Inclusion criteria: not described
Exclusion criteria: not described
Setting: field study in 14 nursing schools (general nurses, paediatric and geriatric nurses,
midwifes), Central Germany
Interventions Comparison of the effectiveness of a:
• training program, versus
• no intervention
The intervention group received regular training (educational lecturewith practical parts)
, and skin care cream (Asche Basis Creme). The lectures took place 3 times in the first
year, 2 times in the second and third year. The nurse apprentices were encouraged to use
alcoholic hand disinfection instead of hand washing or scrubbing. The effect of applying
skin care cream was assessed by the use of a fluorescence technique with the Dermalux-
system as part of the training. Participants in the control group also received the skin
care cream
Outcomes 1. Proportion of OIHD (abnormal morphology = irritant skin changes during
apprenticeship) defined as the occurrence of at least 1 morphology category at 1.5 or 3
years, or both
2. Frequency of treatment discontinuation due to adverse effects: study investigators
state that dropouts were not due to skin problems
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD):
Irritant Skin changes were recorded using the operational definitions of Uter 1998b.
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Strengths
• Clinical examination by physician. Good method to assess prevalence of hand
eczema.
• Differentiation between mild changes and hand eczema (‘moderate’ or ‘severe’)
Limitations
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• Broad outcome definition -> comparatively many cases expected
• Time frame: combined incidence at 1.5 years, 3 years (or both). No information
on hand eczema in between.
Scoring system for the severity of OIHD: no scores assessed
Quality of bioengineering methods (Pinnagoda 1990): not relevant
Notes Demographic data and dropout rates were only available for the entire study population
of 521 nurse trainees
Study funding sources: ’This work was generously supported by a grant from Asche
Chiesi GmbH, Hamburg, Germany.’ (p. 207)
Possible conflicts of interest: not described
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ’Randomly divided’ (p. 203); de-
tails not described
Allocation concealment (selection bias) Unclear risk Method not described.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of participants unclear, possible
influence on proportion of OIHD
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Evaluation of skin changes was performed
by 2 blinded physicians
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Unclear risk No influence of blinding is expected for
these objective measurements
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Low risk Quote: ’The dropout ratewas 37.6%which
was not due to skin problems, but due to
their absence because of illness at the date
of evaluation.’ (p. 204)
Quote: ’For follow up of dropouts, we
performed a telephone interview with the
trainee or (if he could not be reached) with
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his teacher. The aim of this interviewwas to
evaluate, whether or not skin changes were
responsible for the dropout.’ (p. 204)
Low bias because the study investigators
convincingly explain that they ensured no
dropout was related to hand eczema
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk Design: no correction for cluster randomi-
sation -> no bias, but over-precise results
and limited comparability
Baseline imbalances: no imbalances
Blocked randomisation in unblinded tri-
als: no block randomisation reported
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms
Meer 2015
Methods Cluster-randomised controlled trial; 48 clusters (hospital departments)
Parallel design with different recruitment dates, 2 arms
Duration: 12 months
4 follow-ups at 3, 6, 9, and 12 months
Participants Final number evaluable after 12 months: N = 981 initially healthy hospital employees
handling irritants during work (intervention: N = 559; control: N = 422)
After correction for ICC= 0.005:N=893 initially healthy hospital employees handling
irritants during work (intervention: N = 509; control: N = 384)
Number of participants randomised: N = 1649 (intervention: N = 876; control: N =
773)
Excluded from review due to OIHD at beginning of study: N = 144 (intervention:
N = 64; control: N = 80)
Lost to follow-up:N = 524 (intervention: N = 253; control: N = 271) out of the 1505
initially healthy participants
Mean age in years (all included participants): intervention: 40.07 years, SD 11.5;
controls: 40.8 years, SD 11.3
Sex: 78.4% female (intervention), 78.3% female (control)
Inclusion criteria
• Being employed at one of the participating hospitals
• Being able to fill out Dutch questionnaires
• Being aged between 18 and 64 years
• Working for at least 8 hr weekly
Exclusion criteria: not handling irritants during work
Setting: field study in 48 hospital departments (different cities in the Netherlands)
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Interventions Comparison of the effectiveness of:
• a multifaceted implementation strategy, versus
• leaflet only
The multifaceted implementation strategy included participatory working groups, role
modes, educational programme including reminders, and a leaflet. The main recom-
mendations were:
’1. When there is no visible contamination of the hands, use an alcohol-based hand
disinfectant instead of water and soap to
disinfect the hands*
2. Wear gloves when performing wet work
3. Wear cotton undergloves when you wear gloves for longer than 10 min
4. Use a moisturizer on a daily basis to nurse the skin and do not use a body lotion
5. Do not wear jewellery at work
6. Perform as little wet work as possible
* This means that the use of disinfectant should be increased and the use of water and
soap should be decreased.’ (p. 3)
All workers who were present at the educational session received a bag with one mois-
turiser, a pair of cotton undergloves, and two disinfectants (no product names or details
reported). The intervention went on for 4 months. The comparison group received only
the leaflet
Outcomes 1. Proportion of OIHD (hand eczema in the past 3 months) as measured with the
Nordic Occupational Skin Questionnaire - 2002 (NOSQ 2002): Defined as answering
‘yes’ to question D1 (ever had HE) or D2 (ever had eczema on wrists or forearms), and
choosing one of the following answer categories for question D5: ‘I have it just now’ or
‘Not just now, but within the past 3 months’. Assessed at 3, 6, 9, and 12 months
2. A healthy skin score was assessed, but not reported separately for incident cases of
OIHD. This outcome does therefore not fit the review’s outcomes (not extracted).
Study investigators did not evaluate healthy skin score separately for participants in
incident cases (as defined as review outcome).
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD)
Strengths
• The questions used to assess the prevalence of hand eczema belong to a validated
questionnaire (NOSQ 2002).
• Questions cover 3-months-period
Limitations
• Self-reporting of hand eczema underestimates the true prevalence of hand eczema.
Especially mild changes are often not reported.
• No differentiation between hand eczema and eczema on the forearms
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Comparability
• Relatively narrow outcome definition
• Time frame: period prevalence (last 3 months) -> comparatively many cases
expected
Scoring system for the severity of OIHD: ’Workers assessed the health of the skin on
their hands by means of the following question: ‘How would you judge the health of
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your hands/forearms at the moment on a scale from 0 to 10?’ (0, unhealthy skin; 10,
healthy skin). This question was based on question D12 of the NOSQ-2002.’ (p. 4)
Strengths
• Standardised questions that belong to a validated questionnaire (NOSQ 2002)
Limitations
• Self-reporting is less accurate than clinical examination by a physician
• Very subjective, no objective parameter
Quality of bioengineering methods (Pinnagoda 1990): not relevant
Notes Demographic data and only reported for the study population including those with hand
eczema at baseline
Contingency table and dropouts were calculated based on the raw data received from
the study investigators
Study funding sources: ’This study was supported by a grant from the Netherlands
Organization for Health Research and Development (ZONMW).’
Possible conflicts of interest: none declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ’Based on the sequence of inclusion,
randomisation was performed in strata of
two by an independent researcher.’ (Meer
2011, p. 3)
Allocation concealment (selection bias) Unclear risk Not described. Randomisation took place
before baseline measurements by an inde-
pendent researcher and was stratified by
cluster-based criteria. The study investiga-
tors excluded 17 out of 1666 baseline re-
sponders after randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: ’Workers were not informed about
the design of the study and outcome of ran-
domisation.’ (pp. 2-3)
No blinding of personnel and department
managers is expected to introduce only a
low risk
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk OIHD was self-reported and participants
were blinded.
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Unclear risk No influence of blinding is expected for
these objective measurements
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Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Unclear risk Only superficial analysis of dropouts, rea-
sons for dropout unknown. Quote: ‘An-
other limitation was that there was a non-
response rate of >30% at the final follow-
up measurement. However, the differences
between the baseline values of the non-re-
sponders and the baseline values of the to-
tal population were minimal.’ (p. 11)
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Low risk Primary study outcome predefined in strat-
egy and reported; secondary study out-
comes predefined in strategy
Other bias Unclear risk Design: no correction for cluster randomi-
sation -> no bias, but over-precise results
and limited comparability
Baseline imbalances (whole study popu-
lation including participants with HE at
baseline)
• In the intervention group 7.3% had
HE at baseline compared to 10.3% in
control group.
• In the intervention group, 69.4%
performed patient related tasks compared
to 81.2% in control group.
• In the intervention group, 57.4%
had high education compared to 51.7%
in control group.
• -> probably no strong impact on HE
Blocked randomisation in unblinded tri-
als: no block randomisation reported
Differential diagnostic activity: study in-
vestigators speculate that participants of the
intervention group are more aware of HE
and were therefore more likely to report
them: ’The educational session given dur-
ing the intervention period might have in-
creased awareness among the participants
in the intervention group concerning their
hand eczema symptoms. They may have
evaluated their symptoms - which might
have already been present at baseline - dif-
ferently after the educational session. This
might have led to an increase in hand
eczema reports at follow-up as compared
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with the control group that may be inde-
pendent of a change in clinical status.’ (p.
10)
Perrenoud 2001a
Methods Individually randomised controlled trial
Cross-over design, 2 arms
Duration: 2 x 2 weeks
Follow-ups: day 12, day 15, day 26, day 29
Participants Final number evaluable after 2x2 weeks: N = 16 initially healthy 2nd year apprentice
hairdressers (numbers allocated to groups not reported)
Number of participants randomised: N = 21 (numbers allocated to groups not re-
ported)
Lost to follow-up:N = 5 (numbers allocated to groups not reported)
Sex: 20 female out of 21 included participants
Median age (all included participants): 18 (range 16 to 30)
Atopy: 1 had a probable and 3 had a possible atopic disposition
Inclusion criteria: at least 5 times shampooing per day without gloves
Exclusion criteria: hand dermatitis
Setting: field studywith apprentices from themain regional occupational training centre,
Geneva, Switzerland
Interventions Comparison of the effectiveness of:
• a barrier cream Excipial protect, and
• its vehicle
The participants were randomised to start either with barrier cream (Excipial protect)
or with its vehicle. Excipial protect contains aluminium hydroxychloride and glycerine.
Glycerine promotes water retention in the skin and the aluminium salt reduces excess
sweating. The vehicle was designed specifically for skin care for occupational users. The
first creamwas applied 5 days a week for 2 weekswith a washout period of 2 days followed
by another 2-week treatment period with the second cream
Outcomes 1. Proportion of irritant skin changes and OIHD (but as scores for dryness, redness,
breaks in the skin; no quantitative data reported)
2. Biometric: corneometry; chromometry and TEWL; no quantitative values given,
only figures and P values (test and comparison not described sufficiently)
3. Subjective opinion
4. Mild adverse effects
5. Frequency of treatment discontinuation due to adverse effects: The study
investigators stated that the dropouts were ’for reasons not related to the study.’
6. A clinical scores was applied, but without reporting any quantitative data. This
outcome does therefore not fit the review’s outcomes (not extracted).
Participants were assessed at the beginning at day 12, day 15, day 26, and day 29. The
primary outcome measures were the proportion of irritant skin changes (score defined by
study investigators). The secondary outcome measures were the amount of skin barrier
impairment (TEWL), skin hydration (corneometry), and skin colour (chromometry)
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in the groups. A further secondary outcome measure was the subjective opinion of the
participants concerning different features of the creams (ease of use, consistency, oiliness,
protective effect, tolerance, general aspects)
Diagnostic criteria for OIHD (degree of certainty for the diagnosis of OIHD): not
relevant
Scoring system for the severity of OIHD: three scores were assessed: Dryness, redness,
breaks in the skin. Scale of 0 to 3 (0 = none, 1 = mild, 2 = strong, 3 = maximum)
Strengths
• Clinical examination
Limitations
• Only a very limited number of symptoms were documented, many other
symptoms of hand eczema are missing (e.g. vesicles, hyperkeratosis).
• No exclusion of endogenous/atopic hand eczema or allergic contact dermatitis of
the hands (no patch test performed)
• No exclusion of non-occupational hand eczema
Quality of bioengineering methods (Pinnagoda 1990)
’The biometric measurements were taken on the back of the dominant hand. The fol-
lowing instruments
• The Evaporimeter EP2 (ServoMed, Kinna, Sweden) was used to measure the
transepidermal water loss (TEWL). The measurement represents the average over a 15
s period following a 30 s stabilization period.
• The Corneometer 820 PC (Courage and Khazaka, Köln, Germany) measured
skin capacitance as a reflection of moisture. 3 measurements were taken and the average
was calculated.’ (p. 135)
Strengths
• Information is given on instruments and the test room (temperatures, relative
humidity)
• Measurements were taken in a standardized environment (temperature, relative
humidity)
• Measurements always on the same days of the week
• Method is well-described
Limitations
• Measurements were taken on the back of the dominant hand. Rather vague
information. Does not ensure that always the same area was measured.
Notes Not included in meta-analysis because no quantitative data reported
Study funding sources: not described
Possible conflicts of interest: not described
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ’The subjects were randomly as-
signed.’ No further information provided
Allocation concealment (selection bias) Unclear risk No information provided.
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Blinding of participants and personnel
(performance bias)
All outcomes
Low risk The participants were blinded: They re-
ceived 3x 50 g tubes with identical mark-
ings at the beginning of the study and an-
other 3 tubes after 2 weeks
Comment: Probably done
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Quote: ’Double-blind’ (p. 135). Partici-
pants, and outcome assessors were blinded
Comment: Probably done
Blinding of outcome assessment (detection
bias)
TEWL and corneometry
Low risk No influence of blinding is expected for
these objective measurements
Incomplete outcome data (attrition bias)
Hand-eczema-related outcomes
Unclear risk 5 out of 21 apprentices dropped out during
only 4weeks. The study investigators stated
that the dropouts were ’for reasons not re-
lated to the study. Their withdrawal did not
effect the balance between the 2 groups to
which they had been assigned’ (p. 134). No
further details provided. Dropout reasons
unknown although it is doubtful they were
truly unrelated to the study or outcome
Incomplete outcome data (attrition bias)
Consumer satisfaction
Unclear risk The study did not address this outcome.
Selective reporting (reporting bias) Unclear risk Results concerning primary outcome mea-
sure was only summarised briefly. Quote:
’Clinical scores were generally very low...
under either cream’ (p. 136), but not re-
ported separately for verum and vehicle
Other bias Unclear risk Application frequency of barrier cream and
vehicle unclear.
Design: cross-over -> no impact because
no quantitative data for proportion of HE
provided
Baseline imbalances: comparability of
groups at baseline unclear, no details given
Blocked randomisation in unblinded tri-
als: no block randomisation reported
Differential diagnostic activity:no differ-
ent diagnostic activities across study arms
g: gram
HE: hand eczema
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ITT: intention-to-treat
N: number
OIHD: occupational irritant hand dermatitis
RCT: randomised controlled trial
SD: standard deviation
TEWL: transepidermal water loss
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Amphoux 1975 Double-blind CCT: inclusion of workers with hand dermatitis (intervention group: 21.0%, control group 21.
4%), no separate data for healthy workers available. No inclusion of dropouts and withdrawals in the analysis
Arbogast 2004 RCT: only workers with compromised skin were included. Outcome: secondary prevention of OIHD
Bauer 2002 CCT: quality criteria for quasi-RCT not fulfilled. No blinding of participants, clinicians and outcome assessors
Berndt 2000 RCT: only workers with compromised skin were included. Outcome: secondary prevention of OIHD
Bolam 1971 Not randomised, but groups were similar. Housewives.
Bregnhøj 2012 Not randomised. No primary intervention (8 out of 397 apprentices showed HD at inclusion)
Brown 2007 Qualitative study, intervention implementation research, no quantitative data available
Davis 2005 RCT: no field study, laboratory experiment.
Dobson 1979 RCT: effect of industrial hand cleansers on TEWL was evaluated. This type of intervention was not considered
in this review. No data on OIHD, only outcome is TEWL
Frosch 2003 RCT: no separate data for healthy dental technicians available.Only 5 laboratorieswere randomised to 4 products;
only partial cross-over-design (2 out of 4 products were tested in the same laboratory)
Glantz 1976 Probably not randomised. Under field conditions it was only investigated whether or not the protective ointment
had a negative influence on the handling of dental instruments. The protective effects were only measured in a
laboratory experiment
Held 2001 CCT: inclusion of apprentices with hand dermatitis (intervention group 25%, control group 20%), no separate
data for healthy apprentices available. No blinding of participants and clinicians, blinding of outcome assessors
unclear
Held 2002 RCT: inclusion of workers with hand dermatitis (intervention group 25%, control group 30% with two or more
of the following symptoms: redness, vesicles, papules, itching, scaling, dryness, fissuring, rough and thickened,
or suppurate skin changes), no separate data for healthy workers available
McCormick 2000 RCT: only workers with compromised skin were included. Outcome: secondary prevention of OIHD
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Mody 2003 RCT: the objectives were to investigate the impact of an alcohol-based hand rub on knowledge, compliance,
and hand colonisation of healthcare workers. The prevention of OIHD was not addressed
Perrenoud 2001b RCT in an intensive care unit: unclear if only healthy participants were included, only preliminary data available.
No quantitative data on OIHD available
Schwanitz 2003 CCT: inclusion of apprentices with hand dermatitis (intervention group 13.7%, control group 27.8%), no
separate data for healthy apprentices available. No blinding of participants, clinicians, and outcome assessors.
No information on loss to follow-up
Sell 2005 CCT: inclusion of workers with hand dermatitis (12%), data on healthy workers were provided, but study could
not be included because of violation of quality criteria (no blinding of participants, clinicians, and outcome
assessors)
Winker 2009 RCT: Primary and secondary intervention mixed. Winker answered to our emails, but did not provide the
requested data for initially healthy participants (primary prevention). He stated that the number of cases (HE)
would be too small to detect significant differences between groups. This is probably true, but may introduce
reporting bias to our review. Their study included 456 participants without and 27 with HE at baseline. At last
follow-up, 24 participants had eczema
Winnefeld 2000 RCT: Comparison of a non-medicated soap vs an alcohol-based hand rinse: This type of intervention was not
considered in this review. Primary outcome proportion of OIHD was not assessed. Only 8 days of duration
CCT: controlled clinical trial
HE: hand eczema
RCT: randomised controlled trial
OIHD: occupational irritant hand dermatitis
TEWL: transepidermal water loss
Characteristics of studies awaiting assessment [ordered by study ID]
Visscher 2014
Methods Randomised controlled trial
Parallel design, 2 arms
Duration: 4 weeks
3 follow-ups at 1, 2, and 4 weeks
Participants Number of participants randomised: N = 63 intensive care HCWs (over 60% with knuckle dryness and erythema
scores of 2 at baseline)
Setting: hospital
Interventions ’The objective was to determine the effects on hand skin condition of
• a pseudoceramide test cream, designed for moisture barrier repair and substantivity,
• relative to the hospital provided lotion.’
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Visscher 2014 (Continued)
’Application was 33 daily.’
Outcomes ’The primary outcome was skin condition measured as
1. expert visual scoring of dryness and erythema,
2. digital imaging and analysis,
3. stratum corneum integrity (TEWL), and
4. skin hydration (capacitance)
after 1, 2, and 4 weeks.’
Notes Conference publication, only abstract available.
’There was significant irritant dermatitis at baseline as over 60% of HCWs had knuckle dryness and erythema scores
of 2.’
This trial will only be eligible if the data on OIHD is available in a dichotomised form and separately provided for
HCWs without OIHD at baseline
Characteristics of ongoing studies [ordered by study ID]
Madan 2016
Trial name or title A behavioural change package to prevent hand dermatitis in nurses working in the national health service
(the SCIN trial)
Methods Cluster-randomised controlled trial (35 sites)
Parallel design, 4 arms
Duration: 12 months
Participants Nurses working in the National Health Service (NHS) who are particularly at risk
Focus on two groups of staff:
• student nurses who are about to start their first clinical placements, and who are at increased risk of
hand dermatitis because of a past history of atopic disease or hand eczema: Inclusion criteria: student
nurses who are due to start their first clinical placement and have a history of atopic disease or hand eczema
Exclusion criteria: mental health nursing students;
• nurses working in ICUs, who are at increased risk of hand dermatitis because of the nature of their
work Inclusion and exclusion criteria: not specified in the protocol
Sample size: ’Field workers will be encouraged to recruit as many eligible student nurses and ICU nurses as
possible, with the aim of recruiting at least 40 student nurses and 40 nurses from the ICUs at each site.’
Setting: ’12 NHS acute hospital trusts/health boards which provide OH care to both student and ICU nurses,
18 NHS trusts which provide OH care to ICU nurses and 5 university OH departments which provide OH
care to student nurses’
Interventions Comparison of the effectiveness of:
• a bespoke, web-based behavioural change intervention to improve hand care, coupled with provision
of hand moisturisers (’intervention-plus’: ’The BCP will be supported by provision of facilities to encourage
adherence. These will include personal supplies of moisturising cream for at-risk student nurses, and
provision of (1) optimal equipment for cleaning hands, and (2) moisturising cream dispensers on ICUs.’), vs:
• standard care (’intervention-light’: ’Nurses at intervention-light sites will be managed according to
what would currently be regarded as best practice, with provision of an advice leaflet about optimal hand
care entitled ’Dermatitis: occupational aspects of management. Evidence-based guidance for employees’
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Madan 2016 (Continued)
(also provided to the intervention-plus group) and encouragement to contact their OH department early if
hand dermatitis occurs. However, they will not receive the BCP or active reinforcement of its messages. Nor
will they routinely be offered supplies of moisturising cream over and above what is already standard
practice at their site.’)
Outcomes 1. Proportion of objectively assessed hand dermatitis after 1 year
2. Impacts on participants’ beliefs and behaviour regarding hand care (as a measure of adherence)
3. Days off sick over a 1-year follow-up period
4. Use of hand moisturisers
5. Cost-effectiveness of the intervention compared with normal care
Starting date ’At the time of submission, the main trial has been underway since September 2014, with final recruitment
planned for March 2016.’
Contact information ira.madan@kcl.ac.uk
Notes Inclusion and exclusion criteria might be refined. It is unclear whether or not nurses with hand dermatitis
present at baseline will be included
Study funding sources: The SCIN Trial is funded by the National Institute of Health Research, Health
Technology Assessment (HTA) programme grant: NIHR grant number 11/94/01. The trial is sponsored
by the National Institute for Health Research (NIHR) Biomedical Research Centre based as Guy’s and St
Thomas’ NHS Foundation Trust and the UKCRC-registered King’s Clinical Trials Unit at King’s College
London
Possible conflicts of interest: ’There are no competing interests to declare by any of the authors.’
Soltanipoor 2016
Trial name or title The healthy hands project: Effectiveness of a skincare programme for the prevention of contact dermatitis in
healthcare workers
Methods Cluster-randomised controlled trial
Parallel design, 2 arms
Duration: 18 months
Questionnaire every 6 months
Participants Number of participants randomised: healthcare workers (N unknown, 34 wards)
Setting: University Medical Center
Interventions ’The experimental intervention will comprise provision of hand creams in dispensers at the wards, with regular
training and feedback, including reports of the electronically monitored consumption. Both the experimental
and control groups will receive basic education on skin protection (as care as usual).’
Outcomes ’The primary outcome is the change in Hand Eczema Severity Index from baseline to 12 months. The
secondary outcomes are the natural moisturizing factor levels in the stratum corneum as a biomarker of skin
barrier damage, and the total consumption of creams per ward.’
Starting date Probably 2016
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Soltanipoor 2016 (Continued)
Contact information Not known
Notes Conference publication, only abstract available
Unknown whether purely primary prevention
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D A T A A N D A N A L Y S E S
Comparison 1. Barrier creams versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion of OIHD 4 999 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.72, 1.06]
Comparison 2. Moisturisers versus no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion of OIHD 3 507 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.46, 1.09]
Comparison 3. Barrier creams and moisturisers vs no treatment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion of OIHD 2 474 Risk Ratio (M-H, Random, 95% CI) 0.68 [0.33, 1.42]
Comparison 4. Skin protection education versus no or minimal intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Proportion of OIHD 3 1355 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.54, 1.08]
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Analysis 1.1. Comparison 1 Barrier creams versus no treatment, Outcome 1 Proportion of OIHD.
Review: Interventions for preventing occupational irritant hand dermatitis
Comparison: 1 Barrier creams versus no treatment
Outcome: 1 Proportion of OIHD
Study or subgroup
Skin
protection
creams Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Bru¨ning 2008 18/46 14/46 11.3 % 1.29 [ 0.73, 2.27 ]
Duca 1994 99/248 117/249 64.6 % 0.85 [ 0.69, 1.04 ]
Goh 1994 11/17 17/23 19.1 % 0.88 [ 0.57, 1.34 ]
Ku¨tting 2010 8/209 12/161 5.0 % 0.51 [ 0.22, 1.23 ]
Total (95% CI) 520 479 100.0 % 0.87 [ 0.72, 1.06 ]
Total events: 136 (Skin protection creams), 160 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.30, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 1.35 (P = 0.18)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours barrier creams Favours control
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Analysis 2.1. Comparison 2 Moisturisers versus no treatment, Outcome 1 Proportion of OIHD.
Review: Interventions for preventing occupational irritant hand dermatitis
Comparison: 2 Moisturisers versus no treatment
Outcome: 1 Proportion of OIHD
Study or subgroup Skin care creams Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Bru¨ning 2008 15/50 14/46 43.5 % 0.99 [ 0.54, 1.81 ]
Goh 1994 5/14 17/23 30.5 % 0.48 [ 0.23, 1.02 ]
Ku¨tting 2010 10/213 12/161 25.9 % 0.63 [ 0.28, 1.42 ]
Total (95% CI) 277 230 100.0 % 0.71 [ 0.46, 1.09 ]
Total events: 30 (Skin care creams), 43 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 2.23, df = 2 (P = 0.33); I2 =10%
Test for overall effect: Z = 1.58 (P = 0.11)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours moisturisers Favours control
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Analysis 3.1. Comparison 3 Barrier creams and moisturisers vs no treatment, Outcome 1 Proportion of
OIHD.
Review: Interventions for preventing occupational irritant hand dermatitis
Comparison: 3 Barrier creams and moisturisers vs no treatment
Outcome: 1 Proportion of OIHD
Study or subgroup
Skin care
and
protection Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Bru¨ning 2008 14/50 14/46 59.8 % 0.92 [ 0.49, 1.72 ]
Ku¨tting 2010 7/217 12/161 40.2 % 0.43 [ 0.17, 1.07 ]
Total (95% CI) 267 207 100.0 % 0.68 [ 0.33, 1.42 ]
Total events: 21 (Skin care and protection), 26 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.84, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 1.03 (P = 0.30)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours intervention Favours control
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Analysis 4.1. Comparison 4 Skin protection education versus no or minimal intervention, Outcome 1
Proportion of OIHD.
Review: Interventions for preventing occupational irritant hand dermatitis
Comparison: 4 Skin protection education versus no or minimal intervention
Outcome: 1 Proportion of OIHD
Study or subgroup Education Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Flyvholm 2005 15/59 56/153 27.6 % 0.69 [ 0.43, 1.13 ]
Lo¨ffler 2006 69/121 112/129 52.1 % 0.66 [ 0.55, 0.78 ]
Meer 2015 25/509 15/384 20.3 % 1.26 [ 0.67, 2.35 ]
Total (95% CI) 689 666 100.0 % 0.76 [ 0.54, 1.08 ]
Total events: 109 (Education), 183 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 4.44, df = 2 (P = 0.11); I2 =55%
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours education Favours control
A D D I T I O N A L T A B L E S
Table 1. Sensitivity analysis for comparison 1
Excluded trials Rationale for ex-
clusion
Number of
included trials
Number of
included partici-
pants
RR (95% CI) P I2
- - 4 999 0.87 (0.72 - 1.
06)
0.18 9%
Kütting 2010 cluster design
without
correction
3 629 0.89 (0.75 - 1.
06)
0.18 0%
Brüning 2008 split-body
design without
paired analysis
3 907 0.84 (0.70 - 1.
00)
0.05 0%
Brüning 2008
Duca 1994
PO1 was not
manifest
hand dermatitis
2 410 0.75 (0.43 - 1.
29)
0.30 35%
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Table 2. Median skin hydration and TEWL in Brüning 2008
Study arm N Skin hydration1
baseline
Skin hydration1
last follow-up
TEWL2
baseline
TEWL2
last follow-up
Barrier cream +
moisturiser
50 24.73 27.18 17.65 14.9
Moisturiser 50 24.42 26.43 16.93 14.4
Barrier cream 46 25.15 28.5 16 13.68
Control3 46 25.73 27.35 16 14.5
1 Skin hydration measured by corneometry
2 Skin barrier function measured as TEWL (transepidermal water loss, g/m2/h)
3 Differences of interventions compared to the control were not significant at baseline or last follow-up (no P values reported)
Table 3. Median skin hydration and TEWL in Perrenoud 2001
Study arm Skin hydration1
after 11 days control
Skin hydration1
after 11 days
barrier cream
TEWL2 after
11 days
control
TEWL2 after
11 days
barrier cream
Control before
barrier cream
67 60 10 14
Barrier cream
before control
74 64 13 12
Mean of both study arms
3
70.5 62 11.5 13
1 Skin hydration measured by corneometry (units), figures extracted from diagram
2 Skin barrier function measured as TEWL (transepidermal water loss, g/m2/h), figures extracted from diagram
3 Differences of barrier cream compared to control group were significant for skin hydration (P < 0.01) and not significant for TEWL
(no P values reported)
Table 4. Sensitivity analysis for comparison 2
Excluded trials Rationale for
exclusion
Number of
included trials
Number of
included partic-
ipants
RR (95% CI) P I2
- - 3 507 0.71 (0.46 - 1.
09)
0.11 10%
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Table 4. Sensitivity analysis for comparison 2 (Continued)
Kütting 2010 cluster design
without
correction
2 133 0.71 (0.36 - 1.
43)
0.34 53%
Brüning 2008 PO1 was not
manifest
hand dermatitis;
split-body design
2 411 0.55 (0.31 - 0.
94)
0.03 0%
Table 5. Mean skin hydration and TEWL in Halkier-Sørensen 1993
Study arm N Skin hydration1
after 2 weeks
control
Skin hydration1
after 2 weeks
moisturiser
TEWL2
after 2 weeks
control
TEWL2
after 2 weeks
moisturiser
Control before
moisturiser group I3
70 72 80 39 42
Moisturiser before
control group I
70 72 83 40 41
Control before
moisturiser group II
4
0 - - - -
Moisturiser before
control group II
23 66 86 41 37
Mean of both study
arms and both
groups5
- 71.2 82.1 39.7 40.9
1 Skin hydration measured by corneometry (capacitance), figures extracted from diagram
2 Skin barrier function measured as TEWL (transepidermal water loss, g/m2/h), figures extracted from diagram
3 Group 1: participants who completed both periods
4 Group 2: participants who completed the moisturiser period but dropped out of period C after an average of 6 days (1-10 days)
because they developed severe dryness of the skin
5 Differences of moisturiser compared to control were not significant for skin hydration or TEWL (no P values reported)
Table 6. Sensitivity analysis for comparison 3
Excluded trials Rationale for
exclusion
Number of
included trials
Number of
included partic-
ipants
RR (95% CI) P I2
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Table 6. Sensitivity analysis for comparison 3 (Continued)
- - 2 474 0.68 (0.33 - 1.
42)
0.30 46%
Kütting 2010 cluster design
without
correction
1 96 0.92 (0.49 - 1.
72)
0.79 -
Brüning 2008 PO1 was not
manifest
hand dermatitis;
split-body design
1 378 0.43 (0.17 - 1.
07)
0.07 -
Table 7. Sensitivity analysis for comparison 4
Excluded trials Rationale for
exclusion
Number of
included trials
Number of
included partic-
ipants
RR (95% CI) P I2
- - 3 1355 0.76 (0.54 - 1.
08)
0.12 55%
Flyvholm 2005 cluster design
without
correction
2 1143 0.86 (0.43 - 1.
70)
0.66 78%
Löffler 2006 cluster design
without
correction;
PO1 was not
manifest
hand dermatitis
2 1105 0.90 (0.51 - 1.
61)
0.73 54%
Flyvholm 2005
Löffler 2006
cluster design
without
correction
1 893 1.26 (0.67 - 2.
35)
0.47 -
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A P P E N D I C E S
Appendix 1. Cochrane Skin Group Specialised Register search strategy
(((dermat* or eczema or dermatos*) and (occupation* or irritant* or contact) and (hand* or finger* or palm*))) AND (INREGISTER)
[REFERENCE] [STANDARD]
Appendix 2. CENTRAL (Cochrane Library) search strategy
#1 ((dermat* or eczema) and (occupation* or irritant* or contact) and (hand* or finger* or palm*)):ti,ab,kw
#2 MeSH descriptor: [Hand Dermatoses] this term only
#3 MeSH descriptor: [Dermatitis, Occupational] this term only
#4 MeSH descriptor: [Dermatitis, Allergic Contact] this term only
#5 MeSH descriptor: [Dermatitis, Contact] this term only
#6 MeSH descriptor: [Dermatitis, Irritant] this term only
#7 {or #3-#6}
#8 (hand* or finger* or palm*):ti,ab,kw
#9 MeSH descriptor: [Hand] explode all trees
#10 #8 or #9
#11 #7 and #10
#12 #1 or #2 or #11
Appendix 3. MEDLINE (Ovid) search strategy
1. ((dermat$ or eczema) and (occupation$ or irritant$ or contact) and (hand$ or finger$ or palm$)).ti,ab.
2. Hand Dermatoses/
3. Dermatitis, Occupational/
4. Dermatitis, Allergic Contact/
5. Dermatitis, Contact/
6. Dermatitis, Irritant/
7. or/3-6
8. (hand$ or finger$ or palm$).mp.
9. exp Hand/
10. 8 or 9
11. 7 and 10
12. 1 or 2 or 11
13. randomised controlled trial.pt.
14. controlled clinical trial.pt.
15. randomized.ab.
16. placebo.ab.
17. clinical trials as topic.sh.
18. randomly.ab.
19. trial.ti.
20. 13 or 14 or 15 or 16 or 17 or 18 or 19
21. exp animals/ not humans.sh.
22. 20 not 21
23. 12 and 22
[Lines 13-22: Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision-
maximizing version (2008 revision)]
84Interventions for preventing occupational irritant hand dermatitis (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 4. Embase (Ovid) search strategy
1. ((dermat$ or eczema) and (occupation$ or irritant$ or contact) and (hand$ or finger$ or palm$)).ti,ab.
2. hand eczema/
3. occupational eczema/
4. contact dermatitis/
5. exp occupational skin disease/
6. skin allergy/
7. irritant dermatitis/
8. or/3-7
9. exp hand/
10. (hand$ or finger$ or palm$).mp.
11. 9 or 10
12. 8 and 11
13. 1 or 2 or 12
14. crossover procedure.sh.
15. double-blind procedure.sh.
16. single-blind procedure.sh.
17. (crossover$ or cross over$).tw.
18. placebo$.tw.
19. (doubl$ adj blind$).tw.
20. allocat$.tw.
21. trial.ti.
22. randomised controlled trial.sh.
23. random$.tw.
24. or/14-23
25. exp animal/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
26. human/ or normal human/
27. 25 and 26
28. 25 not 27
29. 24 not 28
30. 13 and 29
WH A T ’ S N E W
Last assessed as up-to-date: 17 January 2018.
Date Event Description
17 January 2018 New search has been performed We included five new studies and were able to perform
meta-analyses of four different prevention strategies (up
to four studies per intervention). We identified three on-
going studies. We reassessed risk of bias for the four stud-
ies included in the first review version, in accordance
with the methods outlined in the Cochrane Handbook for
Systematic Reviews of Interventions. For one study (Goh
1994), we selected a different study outcome as matching
the primary review outcome. We chose to use risk ratio,
instead of odds ratio, as the measure of treatment effect
85Interventions for preventing occupational irritant hand dermatitis (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
17 January 2018 New citation required and conclusions have changed We included five new studies and performed meta-analy-
ses of two additional prevention strategies. We reassessed
risk of bias for the four studies included in the first review
version. We chose to use risk ratio, instead of odds ra-
tio, as the measure of treatment effect. We used GRADE
methodology to assess evidence quality and draw conclu-
sions about our certainty in the review findings
H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 6, 2010
Date Event Description
7 October 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
AB was the contact person with the editorial base. AB and HR co-ordinated contributions from the authors. HR worked on the
methods section.
AB and HR obtained data on ongoing and unpublished studies. HR, PE, AB, and HCW independently screened papers against
eligibility criteria. HR, JL, DD, MLS, and AB extracted data for the review. HR, DD, AB, and MLS appraised the risk of bias of the
included trials. HR sought additional information about papers, entered data into Review Manager, and analysed and interpreted the
data. SMJ assessed the diagnostic criteria for the outcomes of the included studies and worked on the final draft of the review. AB, HR,
and HCW judged the quality of the evidence. AB and HR wrote the final draft of the review.
CB worked with AB on the previous published version of the review, provided data extraction templates, advised on the update, and
provided critical appraisal of the draft review.
HR responded to the comments of the referees. HCW gave advice concerning the revisions and the final draft of the review.
AB is the guarantor of the update.
Disclaimer
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Skin
Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews
Programme, NIHR, National Health Service or the Department of Health.
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D E C L A R A T I O N S O F I N T E R E S T
Andrea Bauer: “I have received lecture fees from manufacturers of skin care and protection products (Spirig, Astellas, GSK, and La
Roche-Posay). I was the chief investigator (lead author) of an excluded study (Bauer 2002).”
Henriette Rönsch: none known.
Peter Elsner: “I was the co-author of an excluded study (Bauer 2002).”
Daan Dittmar: none known.
Cathy Bennett: “I am the proprietor of Systematic Research Ltd., and received a consultancy fee for my work on this review.”
Marie-Louise A Schuttelaar: none known.
Judit Lukács: none known.
Swen Malte John: “I have received lecture fees from Galderma, Admirall, and Biogen-Idec.”
Hywel C Williams: “I have helped a team led by Dr Ira Madan in London to design and deliver a national clinical trial to prevent
occupational irritant hand dermatitis in nurses, which is due to start recruiting in late 2014. The study will probably report in 2017
or 2018, and at some point will be eligible for inclusion in this systematic review future update. The trial tests the behavioural package
alongside supply of emollients at work. I was the co-author of an excluded study (Bauer 2002).”
S O U R C E S O F S U P P O R T
Internal sources
• TU Dresden, Germany.
The TU Dresden provided computer workplaces and access to literature.
• Cochrane Skin Group, UK.
The CSG provided financial support and accompanied the entire review process.
External sources
• The National Institute for Health Research (NIHR), UK.
The NIHR, UK, is the largest single funder of the Cochrane Skin Group.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The protocol was completed in 2003, therefore predating the Cochrane ’Risk of bias’ tool. This update was conducted applying the
current version of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), which required some substantial
amendments and modifications. The applied methods were described more clearly in order to comply with theHandbook (Higgins
2011):
• Assessment of risk of bias in included studies was done according to Higgins 2011. The protocol referred to Juni 2001.
• Unit of analysis issues were addressed more clearly according to Higgins 2011. They were not mentioned in the protocol.
• We clarified how heterogeneity was assessed in the Assessment of heterogeneity section of the review. This was not mentioned in
the protocol.
• We clarified in the Assessment of reporting biases section that we planned to create funnel plots but that they could not be
applied due to the small number and methodological heterogeneity of included trials. Reporting bias was not addressed in the
protocol.
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• Data synthesis: the protocol did not define how to deal with multiple outcome data. When this became apparent during data
extraction we decided to extract data from the last available time point of each study. Apart from timing, multiple outcome data were
not an issue in the included studies.
• We have defined our key outcomes (primary outcomes 1 and 2) and presented them in one ’Summary of findings’ table for each
preventive intervention. The protocol did not address key outcomes.
• GRADE methods and ’Summary of findings’ tables were applied in this update. These tools were not available when the
protocol was completed.
Several changes from the protocol were predefined in the proposal (the title registration form) of this update and were adopted in the
update:
• Terminology: in the protocol different terms for OIHD were used, which was leading to confusion. In the proposal of the
update only OIHD was used, except when referring to the terminology applied in study reports.
• We clarified the inclusion criteria and have stated more clearly throughout the review that we include only primary prevention
studies and not studies where participants had existing OIHD, unless the participant population was mixed and disaggregated data
was presented for those participants who were healthy with no OIHD at the start of the study.
• The protocol allowed for the inclusion of quasi-RCTs. We only considered RCTs for this update.
• The protocol listed five categories of interventions. Before starting the update, the comparison of behavioural and psychological
interventions versus no intervention was added to the types of interventions to be reviewed. However, these are elements of the
existing category ’skin protection education’, not a separate category. Accordingly, the Types of interventions section of this review still
lists only the five categories that were specified in the protocol.
• We defined the outcomes under investigation more clearly and numerated them differently (compare Primary outcomes;
Secondary outcomes).
◦ The protocol had only one primary outcome: ’Proportion of participants developing any signs and symptoms of hand
dermatitis (incident cases) as rated by the investigators (physician/nurse) or the participants.’ We amended the definition.
◦ We added a second primary outcome (concerning adverse effects).
◦ We added a more precise definition of the secondary outcome concerning clinical course of signs and symptoms of hand
dermatitis.
◦ We modified the secondary outcome concerning adverse effects, to cover only less severe adverse effects that are not
addressed as a primary outcome.
The following changes from the protocol were also necessary.
• We did not identify any eligible trials in the predefined comparison of complex interventions using barrier creams, moisturisers,
and protective gloves versus no intervention. Instead, we analysed the effects of the combination of barrier creams and moisturisers
versus no intervention.
• The protocol did not clarify which meta-analyses were planned. In this update, meta-analyses were only undertaken for the main
outcome, OIHD, because there were not sufficient comparable data for the meta-analysis of other outcome
• The protocol predefined sensitivity analyses for investigating the impact of lower-quality studies and the potential impact of
missing data. In order to avoid excessive subjective judgment, we clarified that we would only investigate the following
methodological weaknesses in sensitivity analyses: cluster design without correction, split-body or cross-over design, and reporting
only minor signs and symptoms of OIHD (as opposed to manifest OIHD). All but one study had missing data due to attrition.
Dropout rates were sometimes considerably higher than cases of OIHD so that applying worst- or best-case scenarios would have
introduced a large bias. Data needed for other types of ITT assumptions were not available. We therefore did not perform any ITT
calculations and missing data was dealt with descriptively.
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• No standardised mean difference could be calculated for continuous outcomes because the studies did not report sufficient data.
These results were reported descriptively in the review.
• We planned to do subgroup analyses (at less than, and greater than 30 years of age; sex; atopy; occupation). In this review, we did
not analyse subgroups of trials because we could not perform meta-analysis for most outcomes, or too few trials were included per
comparison. We did not analyse subgroups of participants either, because such data were not available. Subgroups were assessed
descriptively only.
• Search methods: we did not correspond with authors and pharmaceutical companies to identify unpublished or ongoing trials,
or grey literature. Instead we expanded the number of trials registers we searched in line with current Cochrane Skin methods.
• We stated in the protocol that we would calculate odds ratios (ORs) as the measure of the treatment effect. However, we chose to
report relative risk (RR) instead for the meta-analyses in this and future review versions because odds ratios are more difficult to
understand and often misinterpreted as risk ratios (Higgins 2011). This decision was made without considering any results which
would have occurred by using odds ratios.
• Split-body designs were eligible for this update.
• For this update, other review authors than predefined in the protocol performed the study selection and extraction.
I N D E X T E R M S
Medical Subject Headings (MeSH)
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